Page 1
PUBLICATIONS by L. Eugene Arnold, M.D., M.Ed. Professor Emereitus of Psychiatry,
Ohio State University (numbered within classes: Books; Chapters; Journal Articles; Abstracts;
Letters and Editorials; Reviews).
BOOKS:
l. Coddington, R.D., Arnold, L.E., Leaverton, D.R. and Rowe, M.: Case Studies in Child
Psychiatry, Medical Examination Publishing Co., Flushing, N.Y., l973.
2. Arnold, L.E.: (Ed.), Helping Parents Help Their Children: A Handbook for
Professionals Who Guide Parents, Brunner/Mazel, N.Y., l978.
3. Arnold, L.E.: (Ed.), Preventing Adolescent Alienation: An Interprofessional Approach,
D.C. Heath & Co., Lexington, Mass., l983.
4. Arnold, L.E., Parents' Survival Handbook, LAMMP Publishing Co., P.O. Box 262,
Sunbury, Ohio, l983.
5. Arnold, L.E.: (Ed.), Parents, Children, and Change, D.C. Heath & Co., Lexington, Mass.,
l985.
6. Arnold, L.E. and Estreicher, D.: Parent-Child Group Therapy: Building Self-Esteem in a
Cognitive-Behavioral Group, Lexington Books, Lexington, Mass., l985.
7. Arnold, L.E.: (Ed.), Childhood Stress, John Wiley & Sons, Inc., New York, New York,
1990.
8. Arnold, L.E.: Contemporary Diagnosis and Management of ADHD. Newtown, PA:
Handbooks in Health Care Co., 2002. 3rd edition 2004.
9. Arnold, L.E.: A Family Guide to ADHD. Newtown, PA: Handbooks in Health Care Co.,
2004.
CHAPTERS IN BOOKS ( = peer reviewed):
l. Corson, S.A., Corson, E.O'L., Kirilcuk, V., Arnold, L.E., & Knopp, W.: Bridging the gap
between psychobiology and medical practice: Development of an animal model for the
study of the hyperkinetic syndrome. In Research in Comprehensive Psychiatry, A
Festschrift for Ralph Patterson, Ed. by H. Goldman, The Ohio State University Press,
Columbus, OH, l972.
2. Corson, S.A., Corson, E.O'L., Kirilcuk, V., Kirilcuk, J., Knopp, W., & Arnold, L.E.:
Differential effects of amphetamine on clinically relevant dog models of hyperkinesis and
stereotype: Relevance to Huntington's Disease. In Advances in Neurology, Vol. l, ed. by
A. Barbeau, T.N. Chase, & G.W. Paulson, Raven Press, l973.
3. Arnold, L.E.: A Humanistic approach to neurochemical research in/children. In
Explorations in Child Psychiatry, ed. by E. James Anthony, Plenum Press, l974.
Page 2
4. Arnold, L.E. & Wender, P.H.: Levoamphetamine's changing place in the treatment of
children with behavior disorders. In Clinical Use of Stimulant Drugs in Children, ed. by
K. Conners. Excerpta Medica Supp., l79-l9l, l974.
5. Corson, S.A., Corson, E. O'L., Gwynne, P. & Arnold, L.E.: Pet-facilitated psychotherapy
in a hospital setting. Current Psychiatric Therapies l5, Jules Masserman, ed., l975.
6. Corson, S.A., Corson, E.O'L., Gwynne, P., Gardner, M., Stinson, B., Smeltzer, D., Parks,
J., Arnold, L.E., & Shultheis, D.: Pet facilitated psychotherapy, in Pet Animals and
Society, R.S. Anderson, ed., Bailliere Tindall, London, l975.
7. Corson, S.A., Corson, E.O'L., Arnold, L.E., & Knopp, W.: Animal models of violence
and hyperkinesis: Interaction of psychopharmacologic and psychosocial therapy in
behavior modification. In Animal Models in Human Psychobiology, ed. by G. Serban &
A. Kling, Plenum Press, l976.
(8-14) The following 7 chapters in Helping Parents Help Their Children: A Handbook for
Professionals Who Guide Parents, ed. by L.E. Arnold, Brunner/ Mazel, N.Y., l977:
8. Arnold, L.E.: Strategies and Tactics of Parent Guidance.
9. Arnold, L.E.: Helping Parents Beat The System.
10. Arnold, L.E., Rowe, M., Tolbert, H.A.: Parents' Groups.
11. Arnold, L.E.: Parents, Prescriptions, Pills, and Pot.
12. Arnold, L.E.: Parents of Hyperactive and Aggressive Children.
13. Arnold, L.E., Hetznecker, W., Phillips, A.: Teachers, Principals, and Parents: Guidance
by Educators.
14. Arnold, L.E., Pacheco, J., Russell, R.M.: Parent Guidance by Pastors.
15. Arnold, L.E.: Disorders of Childhood and Adolescence. In: Psychiatry: Essentials of
Clinical Practice by Ian Gregory, M.D. and D.J. Smeltzer, Little. Brown & Co., Boston,
Mass., l977, revised l983, in revision for DSM-IV.
l6. Arnold, L.E.: Philosophy and Strategy of Medicating Adults with Minimal Brain
Dysfunction. In Psychiatric Aspects of Minimal Brain Dysfunction in Adults, ed. by L.
Bellak, Grune & Stratton, N.Y., l979.
(17-20) The following 4 chapters in Behavioral Problems in Childhood, ed. by S. Gabel, Grune
and Stratton, N.Y., l98l:
17. Tolbert, H.A., Arnold, L.E.: Adjustment Disorders in Childhood and Adolescence:
General Principles of Diagnosis, Treatment, and Prevention.
18. Tolbert, H.A., Arnold, L.E.: Adjustment Disorders in Infancy and Preschool Years.
19. Tolbert, H.A., Arnold, L.E.: Adjustment Disorders in the School-Age Child.
20. Tolbert, H.A., Arnold, L.E.: Adjustment Disorders in Adolescence.
21. Arnold, L.E.: Hyperkinesis by Any Other Name Puzzles the Same: Past, Present, and
Future Investigations. In The Hyperkinetic Child, by C.A. Winchell, Greenwood Press,
Westport, CT., l98l.
Page 3
(22-25) The following 4 chapters in Preventing Adolescent Alienation, ed. by L. Eugene Arnold,
Lexington Books, D.C. Heath & Co., l983:
22. Arnold, L.E., Coles, R., Stovall, B.F., Ferguson, T., Salyer, T.: Unprevented Alienation:
Case Illustration and Group Discussion.
23. Arnold, L.E., Zigler, E., Stovall, B.F., Cunningham, L.L., Ferguson, T., Salyer, T.:
Caretaking Dilemmas: Five Years of Interprofessional Agony.
24. Arnold, L.E., Childs, Jr., J.M.: Teaching Social Responsibility: Preventing Delinquency.
25. Arnold, L.E.: Looking Backward and Forward.
(26-28) The following 3 chapters in Health and Safety, ed. by S. Lazarus, Addison-Wesley, l985:
26. Arnold, L.E.: Thoughts, Feelings, Actions, and Words.
27. Arnold, L.E.: Mental and Emotional Health.
28. Arnold, L.E., Dubin, A.: Physical, Mental, and Emotional Growth.
29. Arnold, L.E.: Psychobiosocial Aspects of Managing Hyperactive Children and Their
Medicine in School. In Expanding Mental Health Interventions in Schools, ed. by I.H.
Berkovitz & J.S. Seliger, Kendall/Hunt, Dubuque, Iowa, l985.
(30-35) The following 6 chapters in Parents, Children, and Change, ed. by L.E. Arnold,
Lexington Books, Lexington, Mass., l985:
30. Barkin, T.W., Arnold, L.E., Dunn, V.B., Harsh, S., King, E., Ross, S.D., Turner, E.V., &
Wienke, P.: Swinging into the 1990's: An Interprofessional Challenge.
31. Arnold, L.E.: Nutrition, Nurture, and New Life: Background and Psychobiology.
32. Shuman, A., Browning, R., Arnold, L.E.: Nutrition, Nurture, and Changing Family
Rituals.
33. Gusler, J., Arnold, L.E.: Feeding Patterns and the Changing Family.
34. Weber, C., Jansen, W., Butler, L., Rothman, P., Sommer, K., Lynch, B., Arnold, L.E.:
Parent/Child Support Systems: Alternatives to Traditional Foster Care.
35. Arnold, L.E.: Opportunity Shock.
(36-37) The following 2 chapters in Psychiatric Disorders in Children and Adolescents, ed. by
B.D. Garfinkel, G.A. Carlson, & E.B. Weller. W.B. Saunders Co., Philadelphia, PA, 1990:
36. Arnold, L.E.: Learning Disorders
37. Arnold, L.E.: Tics and Other Stereotyped Movements.
(38-40) The following 4 chapters in: Childhood Stress, ed. by L. Eugene Arnold, John Wiley &
Sons, Inc., New York, NY, 1990:
38. Arnold, L.E.: Stress in Children and Adolescents: Introduction and Summary
39. Burns, E.M. & Arnold, L.E.: Biological Aspects of Stress: Effects on the Developing
Brain
40. Arnold, L.E. & Carnahan, J.A.: Child Divorce Stress
41. Arnold, L.E.: Case Illustration of Stress Assessment and Interprofessional Prevention
Opportunities
Page 4
42. American Psychiatric Ass'n Committee on Psychiatry & Mental Health in Schools
(consultant to committee): Consultation in Special School Settings. In: APA Committee
on Psychiatry & MH in Schools: Psychiatric Consultation in Schools. Washington, D.C.:
American Psychiatric Ass'n. 1993.
(43-44) The following 2 chapters in Handbook of Child and Adolescent Psychiatry: Clinical
Assessment, ed. by S.I. Harrison & S. Eth (Chief Editor, J. Noshpitz), John Wiley & Sons, New
York. (Invited peer-reviewed chapters).
43. Arnold, L.E. & Jensen, P.S.: Observation and Interview of the Parents
44. Arnold, L.E. & Jensen, P.S.: Interpretive Interview with Child/Adolescent and Parents
45. Arnold, L.E.: Nurturing a Vigorous Treatment Research Methodology: Comparisons of
Adult vs. Child/Adolescent and Psychopharmacological vs. Psychosocial Treatment
Research Methodology. In: Tsiantis, J. & Manolopoulos, S., eds.: Basic Child
Psychiatry, Vol. I: Research & Clinical Papers. Athens: Kastaniotis Publishers (Greek).
1994.
46. Arnold, L.E. & Jensen, P.S.: Attention Deficit Hyperactivity Disorder. In: Kaplan, H. &
Sadock, B., Comprehensive Textbook of Psychiatry, 1995.
47. Arnold, L. E., Stoff, D., Cooke, E. Cohen, DJ, Wright, CB, Kruesi, M, Hattab, J,
Graham, P, Zametkin, A, Castellanos, FX, McMahon, W, & Leckman, JF. Ethical
Issues in biological mental health research with children and adolescents. In: K.
Hoagwood and PS Jensen, eds., Ethical Issues in Mental Health Research with Children
and Adolescents. Mahwah, NJ: Lawrence Erlbaum Associates, 1996, pp. 89-111.
48. Arnold, L.E., Gadow, K., Pearson, D.A., & Varley, C.K. Stimulants (peer-reviewed). in:
M.G. Aman & S. Reiss, eds. Psychotropic Medications and Developmental Disabilities.
Columbus, Ohio: Nisonger Center for MR/DD; distributed by American Association on
Mental Retardation. 1998.
49. Arnold, LE, Janke, I, Waters, B, & Milch, A. Psychoactive Effects of Medical Drugs. In:
Werry, JS, & Aman, MG, Practitioner's Guide to Psychoactive Drugs for Children and
Adolescents --2d Edition. New York: Plenum. 1998, pp 387-412.
Page 5
50. Arnold, LE. Methylphenidate vs. amphetamine: Comparative review. In: Greenhill, LL, &
Osman, BB, Ritalin: theory and Practice, 2d Edition. New York: Mary Ann Liebert.
1999.
51. Arnold, LE, Zametkin A, Caravella L, & Korbly N. Ethical Issues in Neuroimaging
Research with Children & Adolescents. Pp 99-109 in: Functional Neuroimaging in Child
Psychiatry, Ernst M & Rumsey JM, Eds. Cambridge, UK: Cambridge University Press,
in press, 1999.
52. Swanson, JM, Hanley, T, Simpson S, Davies M, Schulte A, Wells K, Hinshaw S, Abikoff H,
Hechtman L, Pelham W, Hoza B, Severe J, Molina B, Odbert C, Forness S, Gresham F,
Arnold LE, Wigal T, Wasdell M, Greenhill LL. Evaluation of Learning Disorders in
Children with a psychiatric disorder: an example from the Multimodal Treatment Study
of ADHD (MTA). In: LL Greenhill, ed. Learning Disabilities: Implications for
Psychiatric Treatment. Washington, DC: American Psychiatric Press, Inc., 2000.
53. Arnold, LE. Treatment Alternatives for attention-deficit/hyperactivity disorder. In: Jensen,
PS & Cooper, J (Eds.). Attention Deficit Hyperactivity Disorder: State of the Science;
Best Practices. Kingston, NJ: Civic Research Institute, 2002.
54. Arnold, L.E. Alternative/Complementary treatments for attention-deficit/hyperactivity
disorder. In: Rogers BT, Montgomery TR, Lock TM, & Accardo PJ, eds.: Attention
Deficit Hyperactivity disorder: The Clinical Spectrum. Timonium, MD: York Press, pp.
197-207, 2001.
55. Aman MG, Lindsay RL, Nash, P, Arnold LE. Individuals with mental retardation. In:
Martin A, Scahill L, Charney DS, & Leckman JF, eds. Pediatric Psychopharmacology:
Principles and Practice. NY: Oxford University Press, 2003, pp. 617-630.
56. Arnold, L.E. & Aman, M.G. Clinical assessment instruments and scales in pediatric
psychopharmacology. in: Martin, A., Scahill, L, Charney, D.S., & Leckman, J.F., eds.
Pediatric Psychopharmacology: Principles and Practice. NY: Oxford University Press,
2002.
57. Arnold, L.E. Die NIMH Mulizentrische, Multimodale Behandlungstudie von Kindern mit
aufmerksamkeitsdefizit/Hyperakitivitatsstorung. Tr. by Isabelle Jahraus. In: Fitzner T.
& Werner S., eds.: Doch unzerstorbar ist mein Wesen...Diagnose AD(H)S -- Schicksal
oder Chance? Belz Taschenbuch 161. Weinheim: Belz Verlag, 2004.
58. Lindsay R & Arnold LE. Stress and attention-deficit/hyperactivity disorder. In:
Encyclopedia of Stress, 2d Edition. Oxford: Elsevier, 2007.
59. Spetie, L & Arnold, LE. Attention Deficit Hyperactivity Disorder. In Lewis’ Child and
Adolescent Psychiatry: A Comprehensive Textbook, Fourth Edition, Martin, A. and
Volkmar, F.R, editors. Baltimore: Wolters Kluwer/Lippincott Williams & Wilkens,
2007 .
60. Spetie, L; Arnold, LE. Alternative Treatments in Adult Attention Deficit Hyperactivity
Disorder. In: ADHD in Adulthood. Jan Buitelaar, Cees Kan, and Phil Asherson, editors.
Cambridge University Press. 2007.
Page 6
61. Ghuman JK, Arnold LE, Anthony BJ. Psychopharmacological and other Treatments in
preschool children with ADHD: Current Evidence and practice. In: Luby JL & Riddle
MA, Eds. Advances in Preschool Psychopharmacology New Rochell, NY: Mary Ann
Liebert Inc., 2008.
62. Mendenhall, A.N., Arnold, L.E., & Fristad, M.A. Parent Counseling, Psychoeducation, &
Parent Support Groups. In M.K. Dulcan (Ed), Textbook of Child and Adolescent
Psychiatry. American Psychiatric Publishing: Chicago, 2009.
63. Spetie L & Arnold LE. Psychopharmacologic perspectives on language and reading
weaknesses. In: Galanter CA & Jensen PS, Eds. DSM-IV-TR, Casebook and Treatment
Guiden for Child Mental health. American Psychiatric Press, 2009.
64. Gleason MM & Arnold LE. Psychopharmacologic perspective on disinhibited attachment.
In: Galanter CA & Jensen PS, Eds. DSM-IV-TR, Casebook and Treatment Guiden for
Child Mental health. American Psychiatric Press, 2009.
65. Aman, M.G., Farmer, C.A., Lindsay, R.L., & Arnold, L.E. (In press, 2009). Individuals with
intellectual disability. In A. Martin, L. Scahill, CJ Kratochvil, Eds. Pediatric
Psychopharmacology: Principles and Practice, Second Edition. New York: Oxford
University Press
66. Arnold LE, Hurt EA, Mayes T, Lofthouse N. Ingestible Alternative and Complementary
Treatments for Attention-Deficit/Hyperactivity Disorder. in: Treating
Attention Deficit Hyperactivity Disorder: Assessment and Intervention in Developmental
Context, Hoza B & Evans SW, eds. Civic Research Institute, Kingston, NJ, 2011.
67. Hurt EA, Lofthouse N, Arnold LE. Non-ingestible Alternative and Complementary
Treatments for Attention-Deficit/Hyperactivity Disorder. Chapter in: Treating
Attention Deficit Hyperactivity Disorder: Assessment and Intervention in Developmental
Context, Hoza B & Evans SW, eds. Civic Research Institute, Kingston, NJ, 2011.
68. Elizabeth Hurt, Ph.D., L. Eugene Arnold, M.Ed., M.D., Michael G. Aman, Ph.D. (In press,
2010). Instruments for Assessment and Monitoring. In A. Martin, L. Scahill, CJ
Kratochvil, Eds. Pediatric Psychopharmacology: Principles and Practice, Second
Edition. New York: Oxford University Press
69. Arnold LE, Aman MG, Handen B (2011). What is the value of medication in autism
spectrum conditions? In: Bolte S & Hallmayer J, Eds. Autism Spectrum Conditions,
Cambridge, MA: Hogrefe Publishing, pp 203-206.
70. Arnold LE, Aman MG, Handen B (2011). Are stimulants useful in autism spectrum
conditions? In: Bolte S & Hallmayer J, Eds. Autism Spectrum Conditions, Cambridge,
MA: Hogrefe Publishing, pp 217-219.
71. Hellings, J.A., Reiersen, A.M., Mao, A.R., Arnold, L.E., Pearson, D.A., Aman, M.G.,
Handen, B.L., & McLaren, J. Attention Deficit Hyperactivity Disorder. (In press, 2015).
In: R. Fletcher, J. Barnhill, & S-A. Cooper (Eds.), Diagnostic manual–Intellectual
disability 2: A textbook of diagnosis of mental disorders in persons with intellectual
Page 7
disability. Kingston, New York: National Association for the Dually Diagnosed Press.
ARTICLES
1. Arnold, L.E.: Detection and management of hyperkinetic children in school. School
Counselor l8, l77-l84, l97l.
2. Arnold, L.E.: Better living? Yes, but not through chemistry. Listen 24, #7, July, l97l.
3. Arnold, L.E.: Control of aggression by advanced grade placement: Criteria and case
history. Journal of School Health 42, 458-459, l972.
4. Arnold, L.E., Leaverton, D.R., Norman, M.: Child Psychiatry Movies. Motive 22-23,
Sept.-Oct., l972.
5. Arnold, L.E., Strobl, D. & Weisenberg, A.: Hyperkinetic adult: Study of the paradoxical
amphetamine response. Journal of the American Medical Association 222, 693-694, l972.
6. Arnold, L.E., Wender, P.H., McCloskey, K. & Snyder, S.: Levoamphetamine and
dextroamphetamine: Comparative efficacy in the hyperkinetic syndrome: Assessment by
target symptom. Archives of General Psychiatry 27, 8l6-822, l972.
7. Knopp, W., Arnold, L.E., Andras, R.A. & Smeltzer, D.: Electronic pupillography:
Predicting amphetamine response in hyperkinetic children. Pharmakopsychiatrie 6,
l58-l66, l972.
8. Arnold, L.E.: The art of medicating hyperkinetic children. Clinical Pediatrics. l2, 35-4l,
l973.
9. Arnold, L.E., Kirilcuk, V., Corson, S.A. & Corson, E. O'L.: Levoamphetamine and
dextroamphetamine: Differential effect on aggression and hyperkinesis in children and
dogs. American Journal of Psychiatry l30, l65-l70, l973.
10. Corson, S.A., Corson, E. O'L., Kirilcuk, V., Arnold, L.E., Knopp, W., & Kirilcuk, J.:
Animal models of naturally occurring hyperkinetic dogs not drug-induced, some of which
respond favorably to amphetamines, others not being affected or becoming worse.
Minimal Brain Dysfunction, The N.Y. Academy of Sciences 205, l32-l38, l973.
11. . Knopp, W., Arnold, L.E., Messiha, F.: Gilles de la Tourette's Disease: Implications for
research in Huntington's Disease. Huntington's Disease Symposium, March 29, l972, Ohio
State University. Edited by A. Barbeau. Advances in Neurology l, l35-l45, l973.
12. Arnold, L.E.: Is this label necessary? Journal of School Health 23, 5l0-5l4, Oct. l973.
13. Arnold, L.E.: What Detroit could do for mental health. Johns Hopkins Magazine 24,
5-6, Sept. l973.
Page 8
14. Arnold, L.E. & Smeltzer, D.: Factor analysis of behavior checklist for child psychiatry
outpatients. Archives of General Psychiatry 30, 799-804, l974. (Also in Inventory of
Marriage and Family Literature, Vol. 3, l974).
15. Arnold, L.E. & Desgranges, L.: What teaching does to teachers: A set of rules for
insightful self-redirection of teacher reaction to pressure. Journal of School Health 64,
46l-463, l974.
16. Arnold, L.E., Krebs, G. & Knopp, W.: Amphetamine treatment of paranoid obsessions:
Case report and biochemical implications. Pharmakopsychiatrie 35, 322-327, l974.
17. Huestis, R.D., Arnold, L.E. & Smeltzer, D.: Caffeine vs. methylphenidate and
d-amphetamine in minimal brain dysfunction: A double-blind comparison. American
Journal of Psychiatry l32:8, l975. Abstracted in Pediatrics Digest, Sept. l976.
18. Arnold, L.E.: Suicide and denial in management of Huntington's and other terminal
debilitating diseases. Archives of Foundation of Thanatology 5(4), 430, l975.
19. Arnold, L.E., Huestis, R.D., Smeltzer, D., Scheib, J., Wemmer, D. & Colner, G.:
Levoamphetamine vs. dextroamphetamine in MBD: Replication, time response and
differential effect by diagnostic group and family rating. Archives of General Psychiatry
33(3):292-301, Mar. l976. Abstracted in Psychiatry Digest, Oct. l976.
20. Arnold, L.E.: Minimal brain dysfunction: A hydraulic parfait model. Diseases of the
Nervous System 37(4), l7l-l73, l976.
21. Arnold, L.E.: Causes of hyperactivity and implications for prevention. The School
Psychology Digest 5:4, l0-22, Fall, l976.
22. Corson, S.A., Corson, E. O'L., Gwynne, P.H. & Arnold, L.E.: Pet dogs as nonverbal
communication links in hospital psychiatry. Comprehensive Psychiatry l8:l, Jan.-Feb.,
l977.
23. Arnold, L.E., Barnebey, N., McManus, J., Smeltzer, D., Conrad, A., Winer, G. &
Desgranges, L.: Prevention by specific perceptual remediation for vulnerable
first-graders: Controlled study and follow-up of lasting effects. Archives of General
Psychiatry 34, l279-l294, Nov. l977.
24. Corson, E. O'L., Corson, S.A., Arnold, L.E. & Knopp, W.: Long-term elimination of
violent behavior by the interaction of psychopharmacologic and psychosocial therapy.
Activitas Nervosa Superior, l9(3), 2l6-2l9, l977.
25. Bhatara, V., Arnold, L.E., Knopp, W. & Smeltzer, D.J.: A survey study of the use of
electropupillogram in predicting response to psychostimulants. Psychopharmacology 57,
l85-l87, l978.
26. Arnold, L.E., Huestis, R., Wemmer, D. & Smeltzer, D.: Differential effect of
amphetamine optical isomers on Bender-Gestalt performance of the minimally brain
dysfunctioned. Journal of Learning Disabilities ll:3, March, l978.
Page 9
27. Arnold, L.E., Christopher, J., Huestis, R. & Smeltzer, D.J.: Methylphenidate vs.
d-amphetamine vs. caffeine in MBD: Controlled comparison by placebo washout design
with Bayes analysis. Archives of General Psychiatry 35:463-473, April, l978.
28. Bhatara, V., Clark, D. & Arnold, L.E.: Behavioral and nystagmus response of a
hyperkinetic child to vestibular stimulation. The American Journal of Occupational
Therapy, 32:5, May-June, l978.
29. Dixon, K.N., Arnold, L.E. & Calestro, K.M.: Father-son incest: Unrecognized
psychiatric disorder? American Journal of Psychiatry l35:7, July, l978.
30. Arnold, L.E.: Megavitamins for MBD: A placebo-controlled study. Journal of
American Medical Association 20:24, Dec. l978.
31. Bhatara, V., Arnold, L.E., Lorance, T. & Gupta, D.: Muscle relaxation therapy in
hyperkinesis: Is it effective? Journal of Learning Disorders l2:3, March, l979.
32. Arnold, L.E., Sheridan, K.: Hyperactivity with tactile defensiveness as a phobia. Journal
of School Health 50(9), 53l-533, November, l980.
33. Bhatara, V., Clark, D.L., Arnold, L.E., Gonsett, R., Smeltzer, D.J.: Hyperkinesis treated
by vestibular stimulation: An exploratory study. Biological Psychiatry l6(3), 269-279,
l98l.
34. Arnold, L.E., Barnebey, N.S., Smeltzer, D.J.: First grade norms, factor analysis and cross
correlation for Conners, Davids & Quay-Peterson Behavior Rating Scales. Journal of
Learning Disabilities l4(5), 269-275, May, l98l.
35. Frye, P.E. & Arnold, L.E.: Persistent Amphetamine-Induced Compulsive Rituals:
Response to Pyridoxine (B6). Biological Psychiatry l6(6), 583-587, l98l.
36. Arnold, L.E., Selinger, S.S. & Koizumi, H.: Limbic Regression with Derepression of
Oedipal Feelings. The American Journal of Psychoanalysis, 4l(l), 8l-84, Spring, l98l.
37. Arnold, L.E.: Follow-up on a Follow-up Study: Pitfalls and Ethical Implications. Journal
of Pediatric Psychology, 7:3, 345-348, l982.
38. Box, J., Arnold, L.E. & Smeltzer, D.J.: Protriptyline Weight Loss in Compulsive Eaters:
A Placebo-Controlled Study, Journal of Psychiatric Treatment and Evaluation 5, 387-39l,
l983.
39. Arnold, L.E., Calestro, K., Bates, W., & Wasserman, M.: Teaching Psychiatric
Interviewing as a Core Physician Skill, Journal of Psychiatric Education 7(l), l02-ll2, l983.
40. Lynn, D.J., Mirkin, B.A., Lanese, D.M., Schmidt, H.S. & Arnold, L.E.: Correspondence
between DSM-II hyperkinetic reaction and DSM-III attention deficit disorder, Journal of
the American Academy of Child Psychiatry 22:4, 349-350, l983.
Page 10
41. Arnold, L.E.: Diet and Hyperkinesis, Integrative Psychiatry 2:5, l88-200, Sept-Oct, l984.
42. Arnold, L.E.: Education for Sale: How the teaching profession could profit by selling
itself on the free market, Nomos: Studies in Spontaneous Order 2:3, l7-l9, Autumn, l984.
43. Arnold, L.E., Clark, D.L., Sachs, L.A., Jakim, S. & Smithies, C.: Vestibular & Visual
Rotational Stimulation as Treatment for Attention Deficit and Hyperactivity, The
American Journal of Occupational Therapy 39:2, 84-9l, February, l985.
44. Houts, C.B., Turbett, J.A., Arnold, L.E., and Kruse, E.: Cost of Medical/Surgical
Pediatric Hospital Days Preventable by Psychiatric Hospitalization, Journal of American
Academy Child Psychiatry 24:2, 227-230, l985.
45. Nemzer, E., Arnold, L.E., Votolato, N.A., McConnell, H.: Amino Acid Supplementation
as Therapy for Attention Deficit Disorder (ADD), Journal of the American Academy of
Child Psychiatry 25, 4:509-513, 1986.
46. Arnold, L.E., Sheridan, K. Estreigher, D.: Multifamily Parent-Child Group Therapy for
Behavior and Learning Disorders, Journal of Child and Adolescent Psychotherapy 3(4):
279-284, 1986.
47. Arnold, L.E.: Family Togetherness: Is it Necessary? Is it Possible? The World & I.
August 1988, pg. 330-335 (not peer-reviewed).
48. Arnold, L.E., Kleykamp, D., Votolato, N.A., Taylor, W.A., Kontras, S.B., Tobin, K.:
Gamma-linolenic Acid for Attention-Deficit Hyperactivity Disorder: Placebo Controlled
Comparison to d-amphetamine. Biological Psychiatry, 25:222-228, 1989.
49. Arnold, L.E.: Organic gardening of the brain. Columbus Physician, May:120-123, 1990
(not peer-reviewed).
50. Arnold, L.E., Votolato, N.A., Kleykamp, D., Baker, G.B., Bornstein, R.A.: Does hair
zinc predict amphetamine improvement of ADHD/Hyperactivity? Inter. J. Neuroscience,
50:103-107, 1990.
51. Arnold, L.E.: Is the increase in human height entirely non-genetic? Medical Hypotheses,
33:161-162, 1990 (not peer-reviewed).
52. Arnold, L.E. and Aman, M.G.: Beta-Blockers in Mental Retardation/ Developmental
Disorders. Journal of Child and Adolescent Psychopharmacology, 1(5):361-373, 1991.
53. Arnold, L.E.: Quantifying the value of human life for cost accounting of safeguards:
Clarifying formulas applied to the clozapine controversy as an example. The Journal of
Clinical Ethics 3(1):103-108, 1992.
54. Aman, M.G., Kern, R.A., McGhee, D.E., & Arnold, L.E. Fenfluramine and
methylphenidate in children with mental retardation and ADHD: clinical and side effects.
J. of American Academy of Child & Adolescent Psychiatry, 32(4):851-859, 1993.
Page 11
55. Arnold, L.E. Treatment Research Methodology Comparisons: Adult vs. Child &
Adolescent, and Psychopharmacological vs. Psychosocial Treatments.
Psychopharmacology Bulletin, 29(1):5-17, 1993.
56. Arnold, L.E. NIMH-Funded Research on ADHD. Ch.A.D.D.er 7(2):23-25, 1993.
(not peer-reviewed).
57. Aman, M.G., Kern, R.A., McGhee, D.E., & Arnold, L.E. Fenfluramine and
methylphenidate in children with mental retardation and ADHD: laboratory effects. J.
Autism & Developmental Disorders 23(3):491-505, 1993.
58. Arnold, L.E. Clinical Pharmacological Issues in Treating Psychiatric Disorders of
Patients with Mental Retardation. Annals of Clinical Psychiatry 5(3):189-197, 1993.
59. Arnold, L.E. Screening and evaluating alternative and innovative psychiatric treatments:
A contextual framework. Psychopharmacology Bulletin 30(1):61-67, 1994.
60. Arnold, L.E., Kleykamp, D., Votolato, N., Gibson, R.A., & Horrocks, L. Potential link
between dietary intake of fatty acids and behavior: Pilot Exploration of Serum lipids in
ADHD. J. Child & Adolescent Psychopharmacology 4(3):171-180, 1994.
61. Arnold, L.E. Some nontraditional (unconventional and/or innovative) psychosocial
treatments for children and adolescents: critique and proposed screening principles. J.
Abnormal Child Psychology 23(1):125-140, 1995.
62. . Richters, J.E., Arnold, L.E., Jensen, PS, Abikoff, HB, Conners, CK, Greenhill, LL,
Hechtman, L, Hinshaw, SP, Pelham, WE, & Swanson, JM. The NIMH collaborative
multisite multimodal treatment study of children with ADHD (MTA): I. Background &
rationale. J. of Amer. Acad. Child & Adolesc. Psychiatry 34(8): 987-1000, 1995.
63. Arnold, L.E., Stoff, D., Cooke, E., Cohen, DJ, Kruesi, M, Wright, CB, Hattab, J,
Graham, P, Zametkin, A, Castellanos, FX, McMahon, W, & Leckman, JF. Ethics of
biological psychiatric research with children and adolescents. J. of Amer. Acad. Child &
Adolesc. Psychiatry 34(7): 929-939, 1995.
64. Arnold, LE. Sex Differences in ADHD: Conference Summary. J. Abnormal Child
Psychology, 24(5): 555-569, 1996.
65. Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G, Hechtman
L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE,
Richters JE, Schiller EP, Severe JB, Swanson JM, Vereen D, Wells KC. Medication
Treatment Strategies in the MTA: Relevance to Clinicians and Researchers. J. of Amer.
Acad. Child & Adolesc. Psychiatry, 35(10):1304-1313, 1996.
66. Arnold LE, Hoagwood K, Jensen PS, Vitiello B. Towards clinically relevant clinical
trials. Psychopharm Bull 33(1): 135-142, 1997.
Page 12
67. Hinshaw, S.P., March, J.S., Abikoff, H., Arnold, L.E., Cantwell, D.P., Conners, C.K.,
Elliott, G.R., Halperin, J., Greenhill, L.L., Hechtman, L.T., Hoza, B., Jensen, P.S.,
Newcorn, J.H., McBurnett, K., Pelham, W.E., Richters, J.E., Severe, J. B., Schiller, E.,
Swanson, J.M., Vereen, D., Wells, K., & Wigal, T. (1997). Comprehensive assessment of
childhood attention-deficit hyperactivity disorder in the context of a multisite, multimodal
clinical trial. Journal of Attention Disorders 1(4):217-234, January, 1997.
68. Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman
L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE,
Richters JE, Schiller EP, Severe JB, Swanson JM, Vereen D, Wells KC. NIMH
Collaborative Multimodal Treatment Study of Children With ADHD (MTA): Design
Challenges and Choices. Archives of Gen. Psychiatry 54:865-870, September, 1997.
69. Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman
L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE,
Richters JE, Schiller EP, Severe JB, Swanson JM, Vereen D, Wells KC. NIMH
Collaborative Multimodal Treatment Study of Children With ADHD (MTA): Design,
Methodology, and Protocol Evolution. J. Attention Disorders 2:141-158, Oct., 1997.
70. Pascualvaca, D.M., Anthony, B.J., Arnold, L.E., Rebock, G.W., Ahearn, M.B., Kellam,
S.G., & Mirsky, A.F. Attentional performance in an epidemiological sample of urban
children: the role of gender and verbal intelligence. Child Neuropsychology 3(1):13-27,
1997.
71. Arnold, LE. Treatment alternatives for attention-deficit/hyperactivity disorder (ADHD).
Journal of Attention Disorders, 3:30-48, 1999.
72. March JS, Conners CK, Arnold LE, Epstein J, Parker S, Hinshaw S, Abikoff H, Molina
B, Wells K, Newcorn J, Schuck S, Pelham WE, Hoza B. The Multidimensional Anxiety
Scale for Children (MASC): Confirmatory factor analysis in a pediatric ADHD sample.
J. Attention Disorders 3(2): 85-90, July, 1999.
73. The MTA Cooperative Group (incl. L.E. Arnold). A 14-Month randomized clinical trial
of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General
Psychiatry, 56:1073-1086, Dec. 1999.
74. The MTA Cooperative Group (incl. L.E. Arnold). Moderators and mediators of treatment
response for children with attention-deficit/hyperactivity disorder. Archives of General
Psychiatry, 56:1088-1096, Dec. 1999.
75. Arnold LE. Methylphenidate vs. Amphetamine: Comparative Review. J. Attention
Disorders, 3(4):200-211, 2000.
76. Aman MG, Arnold LE, Armstrong S. Review of Serotonergic Agents and Perseverative
Behavior in Patients with Developmental Disabilities. Mental Retardation and
Developmental Disabilities Research Reviews 5:279-289, 1999.
77. McDougle, C. J., Scahill, L., McCracken, J. T., Aman, M. G., Tierney, E., Arnold, L. E.,
Freeman, B. J., Martin, A., McGough, J. J., Cronin, P., Posey, D. J., Riddle, M.A., Ritz,
Page 13
L., Swiezy, N. B., Vitiello, B., Volkmar, F. R., Votolato, N.A., & Walson, P. Research
Units on Pediatric Psychopharmacology (RUPP)CAutism network: Background and
rationale for an initial controlled study of risperidone. Child and Adolescent Psychiatric
Clinics of North America 9(1):201-224, 2000.
78. Arnold LE, Aman MG, Martin A, Collier-Crespin A, Vitiello B, Tierney E, Asarnow R,
Bell-Bradshaw F, Freeman BJ, Gates-Ulanet P, Klin A, McCracken JT, McDougle CJ,
McGough JJ, Posey DJ, Scahill L, Swiezy NB, Ritz L, Volkmar F. Assessment in
multisite randomized clinical trials (RCTs) of patients with autistic disorder: The Autism
RUPP network. J. Autism and Developmental Disorders 30(2):99-111, 2000.
79. Arnold LE, Pinkham SM, Votolato N. Does zinc moderate essential fatty acid and
amphetamine treatment of attention-deficit/hyperactivity disorder? J. Child & Adolescent
Psychopharmacology 10(2):111-117, 2000.
80. Hoza B, Owens JS, Pelham WE, Swanson JM. Conners CK, Hinshaw SP, Arnold LE,
Kraemer HC. Parent Cognitions as Predictors of Child Treatment Response in Attention-
Deficit/Hyperactivity Disorder. J. Abnormal Child Psychology, 28(6):569-583, 2000.
81. Hinshaw SP., Owens EB., Wells KC., Kraemer HC., Abikoff HB., Arnold LE., Conners
CK., Elliott G., Greenhill LL., Hechtman L., Hoza B., Jensen PS., March JS., Newcorn
JH, Pelham WE., Swanson JM., Vitiello B, & Wigal T. Family Processes and Treatment
Outcome in the MTA: Negative/Ineffective Parenting Practices in Relation to Multimodal
Treatment. J. Abnormal Child Psychology, 28(6):555-568, 2000.
82. Epstein, JN, Conners, CK, Erhardt, D, Arnold, LE, Hechtman, L, Hinshaw, SP, Hoza, B,
Newcorn, JH, Swanson, JM, & Vitiello, B. Familial Aggregation of ADHD
Characteristics. Journal of Abnormal Child Psychology, 28(6):585-594, 2000.
83. Wells KC, Pelham WE, Kotkin RA, Hoza B, Abikoff HB, Abramowitz A, Arnold LE,
Cantwell DP, Conners CK, Del Carmen R, Elliott GR, Greenhill LL, Hechtman L, Hibbs
E, Hinshaw SP, Jensen PS, March JS, Schiller E, Swanson JM. Psychosocial Treatment
Strategies in the MTA Study: Rationale, Methods, and Critical Issues in Design and
Implementation. J. Abnormal Child Psychology, 28(6):483-505, 2000.
84. March, JS, Swanson, JM, Arnold, LE, Hoza, B, Conners, CK, Hinshaw, S, Hechtman,
L, Kraemer, HC, Greenhill, LL, Abikoff, HB, Elliott, G, Jensen, PS, Newcorn, JH,
Vitiello, B, Newcorn, J, Severe, JB, Wells, KC, Pelham, WE. Anxiety as a Predictor and
Outcome Variable in the Multimodal Treatment Study of Children with ADHD. J.
Abnormal Child Psychology, 28(6):527-541, 2000.
85. Wells, CK, Epstein, JN, Hinshaw, SP, Conners, CK, Klaric, J, Abikoff, HB,
Abramowitz, A, Arnold, LE, Elliot, G, Greenhill, LL, Hechtman, L, Hoza, B, Jensen, PS,
March, JS, Pelham, WE, Pfiffner, L, Severe, J, Swanson, J, Vitiello, B, Wigal, T.
Parenting and Family Stress Treatment Outcomes in Attention Deficit Hyperactivity
Disorder (ADHD): An empirical analysis in the MTA study. J. Abnormal Child
Psychology, 28(6): 543-553 2000.
86. Swanson JM, Kraemer HC., Hinshaw, SP, Arnold, LE, Conners, CK, Abikoff, HB,
Clevenger W, Davies M, Elliott, G, Greenhill, LL, Hechtman, L, Hoza, B, Jensen, PS,
Page 14
March, JS, Newcorn JH, Owens L, Pelham, WE, Schiller E, Severe, J, Simpson S,
Vitiello, B, Wells, CK, Wigal, T, Wu, M. Clinical Relevance of the Primary Findings of
the MTA: Success Rates Based on Severity of ADHD and ODD Symptoms at the End of
Treatment. J. Amer. Acad. Child & Adolesc. Psychiatry, 40:168-179, 2001.
87. Conners CK., Epstein JN., March JS., Angold A., Wells KC., Klaric J., Swanson JM.,
Abikoff HB., Arnold LE., Elliott GR., Greenhill LL., Hechtman L., Hinshaw SP., Hoza
B., Jensen PS., Kraemer HC., Newcorn J., Pelham WE., Severe JB., Vitiello B., Wigal T.
Multimodal treatment of ADHD in the MTA: an alternative outcome analysis J. Amer.
Acad. Child & Adolesc. Psychiatry, 40:159-167, 2001.
88. Greenhill LL, Swanson JM., Vitiello B., Davies M., Clevenger W., Wu M., Severe JB.,
Arnold LE., Abikoff HB, Conners CK., Elliott G., Hechtman L., Hinshaw SP., Hoza B.,
Jensen PS, Kraemer HC., March JS., Newcorn JH., Pelham WE., Wells K., Wigal T
(2001). Impairment and deportment responses to different methylphenidate doses in
children with ADHD: the MTA titration. J. Amer. Acad. Child & Adolesc. Psychiatry
40:180-187, 2001.
89. Vitiello B., Severe JB., Greenhill LL., Arnold LE., Abikoff HB., Bukstein O, Elliott GR.,
Hechtman L., Jensen PS., Hinshaw SP., March JS., Newcorn JH., Swanson JM., and
Cantwell DP. Methylphenidate Dosage for Children with ADHD over Time under
Controlled Conditions: Lessons from the MTA. J. Amer. Acad. Child & Adolesc.
Psychiatry, 40:188-196, 2001.
90. Newcorn JH., Halperin JM., Jensen PS., Abikoff HB., Arnold LE., Cantwell DP.,
Conners CK., Elliott GR., Epstein J., Greenhill LL., Hechtman L., Hinshaw SP., Hoza B.,
Kraemer HC., Pelham WE., Severe JB., Swanson JM., Wells KC., Wigal T., Vitiello B.
Symptom Profiles in Children with Adhd: Effects of Comorbidity and Gender. J. Amer.
Acad. Child & Adolesc. Psychiatry, 40:137-146, 2001.
91. Jensen PS., Hinshaw SP., Kraemer HC., Lenora N., Newcorn JH., Abikoff HB., March
JS., Arnold LE., Cantwell DP., Conners CK., Elliott GR., Greenhill L.L., Hechtman L.,
Hoza B., Pelham WE., Severe JB., Swanson JM., Wells KC., Vitiello B., Wigal T.
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups.
J. Amer. Acad. Child & Adolesc. Psychiatry, 40:147-158, 2001.
92. Arnold LE. Ingestive treatments for learning disorders. Perspectives 27:18-21, 2001.
93. Arnold, LE. Alternative Treatments for Adults with ADHD. in: Wasserstein J, Wolfe
LE, & Lefever FF, eds.: Adult Attention Deficit Disorders: Brain mechanisms and Life
Outcomes. NY: New York Academy of Sciences, PP.310-341, 2001.
94. Arnold, LE. Turn-of-the-century ethical issues in child psychiatric research. Current
Psychiatry Reports 3:109-114, 2001.
95. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff
HB, Elliott G, Hechtman L, Hoza B, March JS, Newcorn JH, Pelham WE, Severe JB,
Vitiello B, Wells KC, Wigal T: AFindings from the NIMH Multimodal Treatment Study
of ADHD (MTA): Implications and Applications for Primary Care Providers.@ J Dev.
Page 15
Behav. Pediatrics, 22:60-73, 2001.
96. Scahill L, McCracken J, McDougle CJ, Aman M, Arnold LE, Tierney E, Cronin P,
Davies M, Ghuman J, Gonzalez N, Koenig K, Lindsay R, Martin A, McGough J, Posey
DJ, Swiezy N, Volkmar F, Ritz L, Vitiello B: Methodological issues in designing a
multisite trial of risperidone in children and adolescents with autism. J. Child &
Adolescent Psychopharmacology 11(4):377-388, 2002.
97. Abikoff HB, Arnold LE, Newcorn J, Elliott G, Hechtman L, Severe JB, Wigal T, Shapiro
C, Cantwell DP, Conners CK, Greenhill LL, Hinshaw SP, Hoza B, Jensen PS, Kraemer
HC, March JS, Pelham WE, Swanson JM, Vitiello B, Wells KC (2002).
Emergency/adjunct services and attrition prevention for randomized clinical trials in
children: The MTA manual-based solution. J. Amer. Acad. Child & Adolesc.
Psychiatry, 41(5):498-504.
98. Rieppi, R., Greenhill, L. L., Ford, R. E., Chuang, S., Wu, M., Davies, M., Abikoff, H.,
Arnold, L. E., Conners, C. K., Elliott, G., Hechtman, L., Hinshaw, S., Hoza, B., Jensen, P.,
Kraemer, H. C., Newcorn, J., Pelham, W., Severe, J., Swanson, J., Vitiello, B., Wells, K.,
Wigal, T. (2002). Socioeconomic status as a moderator of ADHD treatment outcomes. J
Am Acad Child Adolesc Psychiatry, 41(3), 269-277.
99. Abikoff HB., Jensen PS., Arnold LE., Hoza B., Hechtman L., Pollack S., Martin D., Alvir
J., March JS., Hinshaw S., Vitiello B., Newcorn J., Greiner A., Cantwell DP., Conners
CK., Elliott G., Greenhill LL., Kraemer H., Pelham WE., Severe JB., Swanson JM.,
Wells K., Wigal T. (2002). Observed Classroom Behavior of Children with ADHD:
Relationship to Gender and Comorbidity. J. Abnormal Child Psychology, 30:349-359.
100. Swanson JM, Arnold LE, Vitiello B, Abikoff H, Wells KC, Pelham WE, March JS,
Hinshaw SP, Hoza B, Epstein JN, Elliott GR, Greenhill LL, Hechtman L, Jensen PS,
Kraemer HC, Kotkin R, Molina B, Newcorn JH, Owens EB, Severe JB, Simpson S,
Wigal T. Response to Commentary on the Multimodal Treatment Study of ADHD
(MTA): Mining the Meaning of the MTA. J. Abnormal Child Psychology 30:327-332,
Aug. 2002.
101. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network
(McCracken JT, McGough J, Shah B, Cronin P, Hong D, University of California at Los
Angeles; Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, Ohio State University;
McDougle CJ, Posey D, Swiezy N, Kohn A, Indiana University; Scahill L, Martin A,
Koenig K, Volkmar F, Carroll D, Lancor A, Yale University; Tierney E, Ghuman J,
Gonzalez NM, Grados M, Kennedy Krieger Institute; Vitiello B, Ritz L, National Institute
of Mental Health; Davies M, Columbia University; Robinson J, McMahon D, Nathan
Kline Institute). Randomized clinical trial of risperidone for irritability in autism. New
England Journal of Medicine, 2002, 347 (5) 314-321.
102. Arnold LE (2002). Dexmethylphenidate: a Viewpoint. Drugs 62:1906-1907, 2002.
103. Aman, M.G., Buican, B., & Arnold, L.E. Methylphenidate treatment in children with
low IQ and ADHD: Analysis of three aggregated studies. J. Child & Adolescent
Psychopharmacology, 13(1):29-40, 2003.
Page 16
104. Galanter CA, Carlson GA, Jensen PS, Greenhill LL, Davies M, Li W, Shirley Z.
Chuang, SZ, Elliott GR, Arnold LE, March JS, Hechtman L, Pelham WE, Swanson, JM.
2003. Response to Methylphenidate in Children with ADHD and Manic Symptoms in the
MTA Titration Trial. J Child & Adol Psychopharmacology 71(3), 540-552.
105. Arnold L.E., Elliott M., Sachs L, Bird H, Kraemer HC, Wells KC, Abikoff HB,
Comarda A, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B,
Jensen PJ, March JS, Newcorn J, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wigal
T. Effects of Ethnicity on Treatment Attendance, Stimulant Response/dose, and 14-
month Outcome in ADHD. Journal of Consulting and Clinical Psychology, 71(4):713-
727, 2003.
106. Owens, E. B., Hinshaw, S. P., Kraemer, H. C., Arnold, L. E., Abikoff, H. B., Cantwell,
D P., Conners, C. K., Elliot, G., Greenhill, L. L., Hechtman, L., Hoza, B., Jensen, P. S.,
March, J. S., Newcorn, J. H., Pelham, W. E., Richters, J. E., Schiller, E. P., Severe, J. B.,
Swanson, J. M., Vereen, D., Vitiello, B., Wells, K. C., & Wigal, T. What treatment for
whom for ADHD: Moderators of treatment response in the MTA. Journal of Consulting
and Clinical Psychology, 71(3), 540-552, 2003.
107. Arnold LE, Vitiello B, McDougle CJ, Scahill L, Shah B, Gonzalez NM, Chuang S,
Davies M, Hollway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney
E. Parent-defined Target Symptoms Respond to Risperidone in RUPP Autism Study:
Customer Approach to Clinical Trials. J. Amer. Acad. Child & Adolesc Psychiatry, 2003
Dec.; 42(12):1443-1450.
108. Stevens, L., Zhang, W., Peck, L., Kuczek, T., Grevstad, N., Mahon, A., Zentall, S.S.,
Arnold, L. E., and J. R. Burgess (2003) Polyunsaturated fatty acid supplementation in
children with inattention, hyperactivity and other disruptive behaviors. Lipids 38:1007-
1021.
109. Arnold L.E., Chuang S, Davies M, Kraemer HC, Abikoff HB, Conners CK, Elliott GR,
Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PJ, March JS, Newcorn J,
Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. Nine Months of
Multicomponent Behavioral Treatment for ADHD and Effectiveness of MTA Fading
Procedures. J. Abnormal Child Psychology, 32(1):39-51, 2004.
110. The MTA Cooperative Group (incl. L.E.Arnold). The NIMH MTA Follow-up: 24-
month Outcomes of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder
(ADHD). Pediatrics 2004, 113(4):754-761.
111. The MTA Cooperative Group (incl. L.E.Arnold). The NIMH MTA Follow-up:
Changes in Effectiveness and Growth After the End of Treatment. Pediatrics 2004,
113(4):762-769.
112. Martin, A., Scahill, L., Anderson, G.M., Aman, M., Arnold, L.E., McCracken, J.,
McDougle, C.M., Tierney, E., Chuang, S., Vitiello, B., and the Research Units on
Pediatric Psychopharmacology Autism Network: Weight and Leptin Changes among
Risperidone-Treated Youths with Autism: Six-Month Prospective Data. American Journal
Page 17
5/16/2012
of Psychiatry 2004; 161:1125-1127.
113. Hoza, B., Gerdes, A. C., Hinshaw, S. P., Arnold, L. E., Pelham, W. E., Molina, B. S. G.,
Abikoff, H. B., Epstein, J. N., Greenhill, L. L., Hechtman, L., Odbert, C., Swanson, J. M.,
Wigal, T. (2004). Self-perceptions of competence in children with ADHD and comparison
children. Journal of Consulting and Clinical Psychology, 72, 382-391.
114. . Jensen PS, Hoagwood K, Roper M, Arnold LE, Odbert C, Crowe M, Molina BS,
Hechtman L, Hinshaw SP, Hoza B, Newcorn J, Swanson J, Wells K. (2004). The Services
for Children and Adolescents--Parent Interview (SCAPI): Development and Performance
Characteristics. Journal of the American Academy of Child & Adolescent Psychiatry,
43(11):1334-1344.
115. Hoagwood K, Jensen P, Arnold LE, Roper M, Severe J, Odbert C, Molina BS, and the
MTA Cooperative Group. (2004). Reliability of the Services for Children and
Adolescents --Parent Interview (SCAPI). Journal of the American Academy of Child &
Adolescent Psychiatry, 43(11):1345-1354.
116. Arnold LE, Lindsay RL, Conners CK, Wigal S, Levine AJ, Johnson DE, West SA,
Sangal RB, Bohan TP, Zeldis JB. A double-blind placebo-controlled withdrawal trial of
dexmethylphenidate hydrochloride in children with attention-deficit/hyperactivity
disorder. J. Child & Adolescent Psychopharmacology, 14(4):542-554, 2004.
117. . Vitiello B, Aman MG, Scahill L, McCracken JT, McDougle CJ, Tierney E, Davies M,
Arnold LE: Research knowledge among parents of children participating in a randomized
clinical trial. J Am Acad Child Adolesc Psychiatry 2005; 44:1-5.
118. Hoza, B., Gerdes, A. C., Mrug, S., Hinshaw, S. P., Bukowski, W. M., Gold, J. A.,
Arnold, L. E., Abikoff, H. B., Conners, C. K., Elliott, G. R., Greenhill, L. L., Hechtman,
L., Jensen, P. S., Kraemer, H. C., March, J. S., Newcorn, J. H., Severe, J. B., Swanson, J.
M., Vitiello, B., Wells, K. C., & Wigal, T. (2005). Peer-assessed outcomes in the
Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder.
Journal of Clinical Child and Adolescent Psychology, 34, 74-86.
119. McDougle, C.J., Scahill, L., Aman, M.G., McCracken, J.T., Tierney, E., Davies, M.,
Arnold, L.E., Posey, D.J., Martin, A., Ghuman, J.K., Shah, B., Chuang, S.Z., Swiezy,
N.B., Gonzalez, N.M., Hollway, J., Koenig, K., McGough, J., Ritz, L., Vitiello, B.:
Risperidone for the core symptom domains of autism: Results from the RUPP Autism
Network Study. Am J Psychiatry, 2005; 162:1142-1148.
120. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network: Risperidone
treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6
months. American Journal of Psychiatry 2005; 162:1361-1369.
121. Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello
B, Arnold LE, Elliott G, Hechtman L, Newcorn J, Pelham WE, Swanson J, Wells K.
Cost-effectiveness of ADHD TreatmentsFindings from the Multimodal Treatment Study
of Children with ADHD. Am J Psychiatry 2005, 162:1628-1636.
Page 18
5/16/2012
122. Langworthy-Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic
disorder: a review of the literature. Research in Developmental Disabilities 27:254-289,
2006.
123. Hoza, B., Mrug, S., Gerdes, A. C., Hinshaw, S. P., Bukowski, W., M., Gold, J. A.,
Kraemer, H. C., Pelham, W. E., Wigal, T., & Arnold, L. E. (2005). What aspects of peer
relationships are impaired in children with ADHD? Journal of Consulting and Clinical
Psychology, 73, 411-423.
124. Arnold LE, Bozzolo H, Hollway J, Cook, A, DiSilvestro R, Bozzolo D, Crowl L,
Ramadan Y, Williams C. Serum zinc correlates with parent/teacher-rated inattention in
children with attention-deficit/hyperactivity disorder. J. Child & Adolescent
Psychopharmacology 15(4): 628-636, 2005.
125. Arnold LE, DiSilvestro R. Zinc in attention-deficit.hyperactivity disorder. J. Child &
Adolescent Psychopharmacology 15(4):619-627, 2005.
126. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network (incl.
L.E.Arnold): A randomized controlled crossover trial of methylphenidate in pervasive
developmental disorders with hyperactivity. Arch Gen Psychiatry, 2005;62:1266-1274.
127. Vitiello B, Davies M, Arnold LE, McDougle CJ, Aman M, McCracken JT, Scahill L,
Tierney E, Posey DJ, Swiezy NB, Koenig K: Assessment of the integrity of study
blindness in a pediatric clinical trial of risperidone. J Clin Psychopharmacol 2005,
25:565-569.
128. Arnold LE, Elliott M, Lindsay RL, Molina BSG, Cornelius MD, Vitiello B, Hechtman
L, Elliott GR, Newcorn J, Epstein JN, Wigal T, Swanson JM, Wells K. Gestational and
ambient tobacco smoke as predictor of ADHD severity, comorbid ODD/CD, and
treatment response in the MTA. Clinical Neuroscience Research, 5(5-6):295-306, 2005.
129. Santosh PJ, Taylor E, Swanson J, Wigal T, Chuang S, Davies M, Greenhill L, Newcorn
J, Arnold LE, Jensen P, Vitiello B, Elliott G, Hinshaw SP, Hechtman L, Abikoff H,
Pelham WE, Wells K, Posner M. Reanalysis of the Multimodal Treatment Study of
Attention-Deficit/Hyperactivity disorder (ADHD) based on ICD-10 Criteria for
hyperkinetic disorder (HD). Clinical Neuroscience Research, 5(5-6):, 2005.
130. Hechtman L, Etcovitch J, Platt R, Arnold LE, Abikoff HB, Newcorn JH, Hoza B,
Hinshaw SP, Kraemer HC, Wells K, Conners CK, Elliott G, Greenhill LL, Jensen PS,
March JS, Molina B, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wigal T. Does
multimodal treatment of ADHD decrease other diagnoses? Clinical Neuroscience
Research, 5(5-6):273-282, 2005.
131. Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT,
Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzales NM, Swiezy NB,
Ritz L, Koenig K, McGough J, Ghuman JK, Lindsay RL. Acute and long-term safety and
tolerability of risperidone in children with autism. J. Child & Adolescent
Psychopharmacology 15(6):869-884, 2005.
Page 19
5/16/2012
132. Epstein, J.N., Willoughby, M., Valencia, E.Y., Tonev, S.T., Abikoff, H.B., Arnold,
L.E., & Hinshaw, S.P. (2005). The role of children's ethnicity in the relationship between
teacher ratings of ADHD and observed classroom behavior. Journal of Consulting and
Clinical Psychology. 73, 424-434.
133. Galanter C, Pagar D, Jensen PS, Davies M, Li W, Carlson G, Abikoff H, Arnold LE,
Bukstein O, Elliott G, Epstein J, Hechtman L, Newcorn J, Wigal T, and Swanson J:
ADHD and Manic Symptoms: Diagnostic and Treatment Implications. Clin Neuroscience
Research, 5:283-294; 2005
134. Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold
LE, Martin A, Katsovich L, Posey DJ, Shah B, Vitiello B. Effects of short- and long-term
risperidone treatment on prolactin levels in children with autism. Biological Psychiatry,
61:545-550, 2007 (Epublished May 25, 2006).
135. Lecavalier, L., Aman, M.G., Scahill, L., McDougle, C.J., McCracken, J.T., Vitiello, B.,
Tierney, E., Arnold, L.E., Ghuman, J.K., Loftin, R.L., Cronin, P., Koenig, K., Posey, D.J.,
Martin, A., Hollway, J., Lee, L.S., & Kau, A.S.M. (2006). Validity of the Autism
Diagnostic Interview-Revised. American Journal on Mental Retardation, 111(3):199-215.
136. Williams, S.K., Scahill, L., Vitiello, B., Aman, M.G., Arnold, L.E., McDougle, C.J.,
McCracken, J.T., Tierney, E., Ritz, L., Posey, D.J., Swiezy, N.B., Hollway, J., Cronin, P.,
Ghuman, J., Wheeler, C., Cicchetti, D., & Sparrow, S. (2006). Risperidone and adaptive
behavior in children with autism. Journal of the American Academy of Child and
Adolescent Psychiatry, 45(4):431-439.
137. Arnold, L.E. (2006). New ADHD medication options: Advances in long-term treatment
for a chronically impairing condition. Advances in ADHD 1(1):23-29, 2006.
138. Epstein, J.N., Conners, C.K., Hervey, A.S., Tonev, S.T., Arnold, L.E., Abikoff, H.B.,
Elliott, G., Greenhill, L.L., Hechtman, L., Hoagwood, K., Hinshaw, S.P., Hoza, B.,
Jensen, P.S., Kraemer, H.C., March, J.S., Newcorn, J.H., Pelham, W.E., Severe, J.B.,
Swanson, J.M., Wells, K., Vitiello, B., & Wigal, T. (2006). Assessing Medication Effects
in the MTA Study using Neuropsychological Outcomes. Journal of Child Psychology and
Psychiatry, 47, 446-456.
139. Hervey, A., Epstein, J.N., Curry, J.F., Tonev, S., Arnold, L.E., Conners, C.K., Hinshaw,
S.P., Swanson, J.M., & Hechtman, L. (2006). Reaction time distribution analysis of
neuropsychological performance in an ADHD sample. Child Neuropsychology, 12, 125-
140.
140. Arnold LE, Aman MG, Cook AM, Witwer AN, Hall KL, Thompson S, Ramadan Y.
Atomoxetine for hyperactivity in autism spectrum disorders: Placebo-controlled crossover
pilot trial. J. Amer. Academy of Child & Adolesc. Psychiatry, 45(10):1196-1205, 2006.
141. Wells KC, Chi TC, Hinshaw SP, Epstein JN, Pfiffner LJ, Nebel-Schwain M, Owens EB,
Arnold LE, Abikoff H, Cnners CK, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen
PS, March J, Newcorn J, Pelham WE, Severe J, Swanson JM, Vitiello B, Wigal T.
(2006). Treatment-related changes in objectively measured parenting behaviors in the
Multimodal Treatment Study of Children with ADHD. J. Consulting and Clinical
Page 20
5/16/2012
Psychology 74, 649-657, 2006.
142. Lindsay RL, Arnold LE Aman MG, Vitiello B, Posey DJ, McDougle CJ, Scahill L,
Pachler M, McCracken JT, Tierney E, Bozzolo BA. Dietary status and impact of
risperidone on nutritional balance in children with autism: a pilot study. Journal of
Intellectual & Developmental Disability, December 2006; 31(4): 204-209
143. Kratochvil CJ, Newcorn JH, Arnold LE, Duesenberg D, Emslie GJ, Quintana H, Sarkis
EH, Wagner KD, Gao H, Michelson D, Biederman J. Atomoxetine Alone or Combined
with Fluoxetine for Treating ADHD with Comorbid Depressive or Anxiety Symptoms. J.
Amer. Acad. Child & Adolesc. Psychiatry, in press, 2005.
144. Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE,
Posey D, Young C, Shah B, Ghuman J, Ritz L, Vitiello B. A prospective open trial of
guanfacine in children with pervasive developomental disorders. J. Child & Adolescent
Psychopharmacology 16(5):589-598, 2006.
145. Tierney E, Aman MG, Stout DJ, Pappas K, Arnold E, Vitiello B, Scahill ! L, McDougle
CJ, McCracken JT, Wheeler C, Martin A, Posey DJ, Shah B. Parent Satisfaction in a
Multi-Site Trial of Risperidone in Children with Autism: A Social Validity Study.
Psychopharmacology, 2007; 191:149-157. ! Epub 200 6 Nov 23.
Page 21
5/16/2012
146. Foster EM, Jensen PS, Schlander M, Pelham WE, Hechtman L, Arnold LE, Swanson
JM, Wigal T. Treatment for ADHD: Is more complex treatment cost-effective for more
complex cases? Health Services Research 42(1): 165-182, 2007.
147. Wagner A, LeCavalier L, Arnold LE, Aman MG, Scahill L, Stigler KA, Johnson CR,
McDougle CJ, Vitiello B. ( 2007) Developmental disabilities modification of the
Children=s Global Assessment Scale. Biol. Psychiatry 2007; 61:504-511.
148. Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B,
Chuang SZ, Davies M, Ramadan Y, Witwer A, Swiezy NB, Cronin P, Shah B, Carroll
DH, Young C, Wheeler C, McDougle CJ: Positive effects of methylphenidate on
inattention and hyperactivity in pervasive developmental disorders: An analysis of
secondary measures. Biol Psychiatry, 61:538-544, 2006.
149. Scahill, L., McDougle, C.J., Williams, S., Dimitropoulos, A., Aman, M.G., McCracken,
J., Tierney, E., Arnold, L.E., Lam, K.L. Vitiello, B.. (2006). The Children=s Yale-Brown
Obsessive-Compulsive Scales modified for pervasive developmental disorders. Journal of
the American Academy of Child and Adolescent Psychiatry, 45, 1114-1123.
150. Spetie L., Arnold L.E. (2007). Ethical issues in child psychopharmacology research and
practice: emphasis on preschoolers. Psychopharmacology, 191(1):15-26, 2007.
151. Johnson CR, Handen BL, Butter E, Wagner A, Mulick J, Sukholdosky DG, Williams S,
Swiezy NA, Arnold LE, Aman MG, Scahill L, McDougle CJ, Stigler KA, Vitiello B,
Smith T (2007). Development of a parent training program for children with pervasive
developmental disorders. Behavioral Interventions 22:201-221.
152. RUPP Autism Network (incl. LE Arnold), 2007. Parent training for children with
pervasive developmental disorders: a multisite feasibility trial. Behavioral Interventions
22: 179-199.
153. Jensen PS, Arnold LE, Swanson J, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L,
Hinshaw SP, Pelham WE, Wells KC, Conners CK, Elliott GR, Epstein J, Hoza B, Molina
BSG, Newcorn JH, Severe JB, Wigal T, Gibbons RD, Hur K. Follow-up of the NIMH
MTA study at 36 months after randomization. Journal of the American Academy of Child
and Adolescent Psychiatry 46(8):988-1001, 2007.
154. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L,
Epstein J, Pelham W, Abikoff HB, Newcorn J, Molina B, Hinshaw S, Wells K, Hoza B,
Severe JB, Jensen PS, Gibbons R, Hur K, Stehli A, Davies M, March J, Caron M, Volkow
ND, & Posner MI, for the MTA Cooperative Group. Effects of stimulant medication on
growth rates across 3 years in the MTA follow-up. Journal of the American Academy of
Child and Adolescent Psychiatry 46(8):1014-1026, 2007.
155. Swanson JM, Hinshaw SP, Arnold, LE, Gibbons R, Marcus S, Hur K, Jensen PS,
Vitiello B, Abikoff H, Greenhill LL, Hechtman L., Pelham W, Wells K, Conners CK,
Page 22
5/16/2012
Elliott G, Epstein J, Hoagwood K, Hoza B, Molina B, Newcorn JH, Severe J, Odbert C,
Wigal T, and the MTA Cooperative Group (in press). Secondary evaluations of MTA 36-
month outcomes: Propensity score and growth mixture model analyses. Journal of the
American Academy of Child and Adolescent Psychiatry 46(8):1002-1013, 2007.
156. Molina, B.S.G., Flory, K., Hinshaw, S.P., Greiner, A.R., Arnold, L.E., Swanson, J.,
Hechtman, L., Jensen, P.S., Vitiello, B., Hoza, B., Pelham, W.E., Elliott, G.R., Wells,
K.C., Abikoff, H. B., Gibbons, R.D., Marcus, S., Epstein, J., Greenhill, L.L., Newcorn,
J.H., Severe, J. B., Wigal, T. (in press). Delinquent behavior and emerging substance use
in the MTA at 36-months: Prevalence, course, and treatment effects. Journal of the
American Academy of Child and Adolescent Psychiatry 46(8):1027-1039, 2007.
157. Gerdes, A. C., Hoza, B., Arnold, L. E., Pelham, W. E., Swanson, J.M., Wigal, T., &
Jensen, P. S. (2007). Maternal depressive symptomatology and parenting behavior:
Exploration of possible mediators. Journal of Abnormal Child Psychology, 35, 705-714.
158. Findling RL, Arnold LE, Greenhill LL, Kratochvil CJ, McGough JJ. Diagnosing
and Managing Complicated ADHD. J. Clin. Psychiatry 68:, 2007.
159. Arnold LE, Lindsay RL, Lopez FA, Jacob SE, Biederman J, Findling RL,
Ramadan Y. Treating attention-deficit/hyperactivity disorder with a stimulant transdermal
patch: the clinical art. Pediatrics 120(5):1100-1106, 2007.
160. Stevens J, Kelleher K, Greenhouse J, Chen G, Xiang H, Kaisar E, Jensen PS, Arnold
LEA. Empirical evaluation of the generalizability of the sample from the Multimodal
Treatment Study for ADHD, Administration and Policy in Mental Health, 34:221-32, 2007
161. Sukhodolsky, D.G., Scahill, L., Gadow, K.D., Arnold, L.E., Aman, M.G.,
McDougle, C.J., MacCracken, J.T, Tierney, E., Williams White, S., Lecavalier, L.,
Vitiello, B. Parent-Rated Anxiety Symptoms in Children with Pervasive Developmental
Disorders: Frequency and Association with Core Autism Symptoms and Cognitive
Functioning Journal of Abnormal Child Psychology 36:117-128, 2008.
162. Langberg, J.M., Epstein, J.N., Altaye, M., Molina, B.S.G., Arnold, L.E., & Vitiello, B.
The transition to middle school is associated with changes in the developmental trajectory
of ADHD symptomatology in young adolescents with ADHD. Journal of Clinical Child
and Adolescent Psychology 2008; 37(3): 651-663.
163. Arnold LE. Alternative and Complementary Treatments for AD/HD. Attention!
August, 2006, pp.30-35.
164. Arnold LE, Bozzolo H, Amato A, Hollway J, Cook A, Ramadan Y, Crowl L, Zhang D,
Thompson S, Testa G, Kliewer V, Wigal T, McBurnett K, Manos M. Acetyl-l-carnitine
(ALC) in attention-deficit/hyperactivity disorder (ADHD): a multi-site placebo-controlled
pilot trial. J. Child & Adolescent Psychopharmacology 17(6):791-801, 2007.
Page 23
5/16/2012
165. Gilchrist R, Arnold LE. Long-term Efficacy of ADHD Pharmacotherapy in Children.
Pediatric Annals, 37(1):46-51, 2008; reprinted in Psychiatric Annals, 38(1):52-57, 2008.
166. Clark DL, Arnold LE, Crowl LA, Bozzolo H, Peruggia M, Ramadan Y, Bornstein R,
Hollway JA, Thompson S, Malone K, Hall KL, Shelton SB, Bozzolo, DR, Cook A.
Vestibular stimulation for attention-deficit/hyperactivity disorder (ADHD): Randomized
controlled trial of comprehensive motion apparatus. J. Attention Disorders 11(5):599-
611, 2008.
167. Gerdes, A.C., Hoza, B., Arnold, L.E., Hinshaw, S.P., Wells, K.C., Hechtman, L.,
Greenhill, L.L., Swanson, J.M. Pelham, W.E., & Wigal, T. Child and Parent Predictors
of Perceptions of Parent-Child Relationship Quality. J. Attention Disorders, 11:37-48,
2007.
168. Spellecy R, Arnold LE, May T. Parents and Children as Members of the Research
Team: Fair Employment Practices without a Union Contract. Ethics and Behavior, 18:1-
16, 2008.
169. Aman, M.G., Farmer, C.A., Hollway, J.A., & Arnold, L.E. (2008). Treatment of
Inattention, overactivity, and impulsiveness in autism spectrum disorders. Child and
Adolescent Psychiatric Clinics of North America 17, 713–738.
170. Jahromi LB, Kasari CL, McCracken JT, Lee LS, Aman MG, McDougle CJ, Scahill L,
Tierney E, Arnold LE, Vitiello B, Ritz L, Witwer A, Kustan E, Ghuman J, Posey DJ.
Positive Effects of Methylphenidate on Social Communication and Self-Regulation in
Children with Pervasive Developmental Disorders and Hyperactivity. J Autism Dev
Disord. 39:395-404, 2009.
171. Nikolov RN, Bearss KE, Lettinga J, Erickson C, Rodowski M, Aman MG, McCracken
JT, McDougle CJ, Tierney E, Vitiello B, Arnold LE, Shah B, Posey DJ, Ritz L, Scahill L.
Gastrointestinal Symptoms in a Sample of Children with Pervasive Developmental
Disorders. J Autism Dev Disord. 39(3):405, 2009.
172. Arnold, L.E. What child and adolescent psychiatry means to me. Mens Sana
Monographs 6(1):131-134, 2008. (In: Medicine, Mental health, Science, Religion, &
Wellbeing, Singh AR & Singh SA, eds.)
173. Ghuman JK, Arnold LE, Anthony B. Psychopharmacological and Other Treatments in
Preschool Children with Attention-Deficit/Hyperactivity Disorder: Current Evidence and
Practice. J. Child & Adolescent Psychopharmacology 18(5):413-447, 2008.
174. Arnold, L. E., Swanson, J. M., Hechtman, L., Vitiello, B., Molina B. S. G., Jenson, P.,
Hinshaw, S. P., & Wigal, T. (2008). Understanding the 36-month MTA follow-up
findings in context. Attention! 15(2), 14-18.
175. Murray, D.W., Arnold, L.E., Swanson, J., Wells, K., Burns, K., Jensen, P., Hechtman,
Page 24
5/16/2012
L., Paykina, N., Legato, L., Strauss, T. (2008). A Clinical Review of Outcomes of the
Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder
(MTA). Current Psychiatry Reports, 10(5), 424-431.
176. James Swanson, L. Eugene Arnold, Helena Kraemer, Lily Hechtman, Brooke Molina,
Stephen Hinshaw, Benedetto Vitiello, Peter Jensen, Ken Steinhoff, Marc Lerner, Laurence
Greenhill, Howard Abikoff, Karen Wells, Jeffery Epstein, Glen Elliott, Jeffrey Newcorn,
Betsy Hoza, Timothy Wigal, MTA Cooperative Group. Evidence, Interpretation, and
Qualification From Multiple Reports of Long-Term Outcomes in the
MultimodalTreatment Study of ChildrenWith ADHD (MTA)Part I: Executive Summary.
J. of Attn Disorders 12(1):4-14, 2008.
177. James Swanson, L. Eugene Arnold, Helena Kraemer, Lily Hechtman, Brooke Molina,
Stephen Hinshaw, Benedetto Vitiello, Peter Jensen, Ken Steinhoff, Marc Lerner, Laurence
Greenhill, Howard Abikoff, Karen Wells, Jeffery Epstein, Glen Elliott, Jeffrey Newcorn,
Betsy Hoza, Timothy Wigal, MTA Cooperative Group. Evidence, Interpretation, and
Qualification From Multiple Reports of Long-Term Outcomes in the
MultimodalTreatment Study of Children with ADHD (MTA) Part II: Supporting details.
J. of Attn Disorders 12(1):15-43, 2008.
174. Goodman B, Arnold LE. Diet and AD/HD. Attention! 15(6):10-13, 2008.
178. Arnold LE. Alternative/complementary Treatments. Attention! 15(6):15, 2008.
179. Findling RL, Bukstein OG, Melmed RD, Lopez FA, Sallee FR, Arnold LE, Pratt RD. A
randomized double-blind placebo-controlled parallel-group study of methylphenidate
transdermal system in pediatric patients with ADHD. Journal of Clinical Psychiatry
69:149-159, 2008.
175. Aman M.G, Hollway J.A., Leone S., Masty J., Lindsay R.L., Nash P., Arnold L.E.
Effects of risperidone on cognitive-motor performance and motor movements in
chronically medicated children. Research in Developmental Disabilities 30 (2009) 386–
396
176. Molina, B.S.G., Hinshaw S.P., Swanson J.M., Arnold, L.E., Vitiello, B., Jensen, P.S.,
Epstein, J.N., Hoza, B., Hechtman, L., Abikoff, H.B., Elliott, G.R., Greenhill, L.L.,
Newcorn, J.H., Wells, K.C., Wigal, T.L., Gibbons, R.D., Hur, K., Houck, P.R., and the
MTA Cooperative Group. (in press). The MTA at 8 Years: Prospective Follow-Up of
Children Treated for Combined Type ADHD in a Multisite Study. Journal of the
American Academy of Child and Adolescent Psychiatry 48(5):484-500, 2009.
177. Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman
L, Chuang S, Wells KC, Pelham WE, Cooper T, Elliott G, Newcorn JH. Medication
Adherence in the MTA: Saliva Methylphenidate Samples versus parent report and
mediating effect of concomitant behavioral treatment. Journal of the American Academy
of Child and Adolescent Psychiatry 48(5):501-510, 2009.
Page 25
5/16/2012
178. Danner S, Fristad MA, Arnold LE, Youngstrom EA, Birmaher B, Horwitz SM, Demeter
C, Findling RL, Kowatch RA, The LAMS Group. Early-Onset Bipolar Spectrum
Disorders: Diagnostic Issues. Clin Child Fam Psychol Review 12:271-293, 2009.
179. Frazier EA, Fristad MA, Arnold LE. Multinutrient Supplement as Treatment: Literature
Review and Case Report of a 12-Year-Old Boy with Bipolar Disorder. Journal of Child
and Adolescent Psychopharmacology August 2009, Vol. 19, No. 4: 453-460.
180. Galanter CA, Pagar DL, Davies M, Li W, Carlson GA, Abikoff HA, Arnold LE, Bukstein
O, et al. ADHD and manic symptoms: Diagnostic and treatment implications. Clinical
Neuroscience Research 5:283–294, 2005.
181. Aman, M.G., Hollway, J.A., McDougle, C.J., Scahill, L., Tierney, E., McCracken, J.,
Arnold, L.E., Vitiello, B., Ritz, L., Gavaletz, A., Cronin, P., Swiezy, N.B., Wheeler, C.,
Koenig, K., Ghuman, J., & Posey, D.J. (2008). Cognitive effects of risperidone in children
with autism and irritable behavior. Journal of Child and Adolescent Psychopharmacology,
18, 227-236.
182. Langberg, J.M., Arnold, L.E., Flowers, A.M., Altaye, M., Epstein, J.N., & Molina, B.S.G.
(in press). Assessing homework problems in children with ADHD: Validation of a parent-
report measure and evaluation of homework performance patterns. School Mental Health
DOI 10.1007/s12310-009-9021-x (on-line), November, 2009.
180. Bukstein OG, Arnold L,E,, Landgraf JM, Hodgkins P. Does switching from oral
extended-release methylphenidate to the methylphenidate transdermal system affect
health-related quality-of-life and medication satisfaction for children with attention-
deficit/hyperactivity disorder? Child and Adolescent Psychiatry and Mental Health,
2009, 3:39-51.
181. Aman MG, McDougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA,
Bears K, Butter E, Swiezy N, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R,
LeCavalier L, Kohn AE, Koenig K, Hollway JA, et al; Research Units on Pediatric
Psychopharmacology Autism Network. Medication and Parent Training in Children with
Pervasive Developmental Disorders and Serious Behavior Problems: Results from a
Randomized Clinical Trial. J. American Academy Child & Adolescent Psychiatry,
2009;48(12):1143-1154.
182. Johnson CR, Butter,Handen BL, Sukhodolsky DG, Mulick J, Lecavalier L, Aman
MG, Arnold LE, Scahill L, Swiezy N, Sacco K, Stigler KA, Mcdougle CJ. Standardised
observation analogue procedure (SOAP) for assessing parent and child behaviours in
clinical trials. Journal of Intellectual & Developmental Disability 34(3):230-238, 2009.
183. Chowdhury, M., Aman, M.G., Scahill, L., Swiezy, N.B., Arnold, L.E., Lecavalier, L.,
Johnson, C.R., Handen, B.L., Stigler, K.A., Bears, K., Sukhodolsky, D.G., & McDougle,
C.J. (2009). The Home Situations Questionnaire–PDD Version: Factor structure and
Page 26
5/16/2012
Psychometric Properties. Journal of Intellectual Disabilities Research, 54, 281-291.
184. Mrug, S., Hoza, B., Gerdes, A.C., Hinshaw, S.P., Arnold, L.E., Hechtman, L., &
Pelham, W.E. (2009). Discriminating between children with ADHD and classmates: The
utility of peer variables. Journal of Attention Disorders, 12, 372-380/.
185. Faraone, S. V., Glatt, S. J., Bukstein, O. G., Lopez, F. A., Arnold, E., & Findling, R. L.
Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children
with ADHD. Journal of Attention Disorders. 2009 12:308-315, originally published online
9 April 2008, DOI: 10.1177/1087054708314844
186. Arnold L, Bozzolo D, Hodgkins P, McKay M, Beckett-Thurman L, Greenbaum M,
Bukstein O, Patel A. Switching from oral extended-release methylphenidate to the
methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder
symptom control and tolerability after abrupt conversion. Current Medical Research &
Opinion. 2010; 26(1):129-137.
187. Arnold, L., Farmer, C., Kraemer, H., Davies, M., Witwer, A., Chuang, S., DiSilvestro,
R., McDougle, C., McCracken, J., Vitiello, B., Aman, M., Scahill, L., Posey, D., &
Swiezy, N. (2010). Moderators, mediators, and other predictors of risperidone response in
children with autistic disorder and irritability. Journal of Child and Adolescent
Psychopharmacology, 20(2), 83-93.
188. Mikami, A. Y., Hinshaw, S. P., Arnold, L. E., Hoza, B., Hechtman, L., Newcorn, J. H., &
Abikoff, H.B. (2010) Bulimia nervosa symptoms in the Multimodal Treatment Study of
Children with ADHD. International Journal of Eating Disorders, 43(3), 248-259.
189. Langberg, J. M., Arnold, L. E., Flowers, A. M., Epstein, J. N., Altaye, M., Hinshaw, S.
P., Swanson, J. M., Kotkin, R., Simpson, S., Molina, B.S.G., Jensen, P.S., Abikoff, H.,
Pelham, W. E., Vitiello, B., Wells, K.C., & Hechtman, L. (2010). Parent-reported
homework problems in the MTA study: Evidence for sustained improvement with
behavioral treatment. Journal of Clinical Child and Adolescent Psychology, 39, 220-223.
190. McCracken JT. Aman MG. McDougle CJ. Tierney E. Shiraga S. Whelan F. Arnold LE.
Posey D. Ritz L. Vitiello B. Scahill L. Possible influence of variant of the P-glycoprotein
gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive
developmental disorders and hyperactivity. Journal of Child & Adolescent
Psychopharmacology. 20(1):1-5, 2010 Feb.
191. Langberg, J. M., Epstein, J. N., Simon, J. O., Loren, R. E. A., Arnold, L. E., Hechtman,
L., Hinshaw, S. P., Hoza, B., Jensen, P. S., Pelham, W. E., Swanson, J. M., & Wigal, T.
(2010). Parent Agreement on Ratings of Children's Attention Deficit/Hyperactivity
Disorder and Broadband Externalizing Behaviors. Journal of Emotional and Behavioral
Disorders, 18(1), 41-50.
Page 27
5/16/2012
192. Jones, H. A., Epstein, J., Hinshaw, S., Owens, E. B., Chi, T. C., Arnold, L. E., Hoza,
B., & Wells. K. C. (2010). Ethnicity as a moderator of treatment effect on parent-child
interaction for children with ADHD. Journal of Attention Disorders, 13, 592-600.
193. Hoza, B., Murray-Close, D., Arnold, L. E., Hinshaw, S. P., Hechtman, L., & the MTA
Cooperative Group. (2010). Time-dependent changes in positively biased self-perceptions
of children with attention-deficit/hyperactivity disorder: A developmental
psychopathology perspective. Development and Psychopathology, 22, 375-390.
194. Horwitz SM, Demeter CA, Pagano ME, Youngstrom EA, Fristad MA, Arnold LE,
Birmaher B, Gill MK, Axelson D, Kowatch RA, Frazier TW, Findling RL. Longitudinal
Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening
results. J Clin Psychiatry. 2010 Oct 5; [Epub ahead of print]
195. Findling RL, Youngstrom EA, Fristad MA, Birmaher B, Kowatch RA, Arnold LE,
Frazier TW, Axelson D, Ryan N, Demeter CA, Gill MK, Fields B, Depew J, Kennedy
SM, Marsh L, Rowles BM, Horwitz SM. Characteristics of children with elevated
symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study. J
Clin Psychiatry. 2010 Oct 5; [Epub ahead of print]
196. Youngstrom, E.A., Arnold, L.E., & Frazier, T.W. Bipolar and ADHD comorbidity: Both
artifact and outgrowth of shared mechanisms. Clinical Psychology: Science and Practice
17:350–359, 2010. Special issue: Comorbidity (Editors: Phillip Kendall and Deborah
Drabick)
197. . Arnold LE. Ask the Expert. On Campus, August 11, 2010.
http://oncampus.osu.edu/2010/08/l-eugene=arnold-professor-emeritus-in-psychiatry/
198. Arnold LE. Do environmental toxins contribute to ADHD symptoms? Attention,
Vol.17, No. 6, December, 2010, pp.8-11.
199. Calarge C, Farmer C, Disilvestro R, Arnold LE. Serum ferritin and amphetamine
response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc
Psychopharmacol. 2010 Dec;20(6):495-502.
200. Lofthouse, N, McBurnett, K Hurt, E & Arnold, LE (2011). Biofeedback &
Neurofeedback Treatments for ADHD. Psychiatric Annals, 41, 42-48.
201. Hurt EA, Lofthouse N, Arnold LE (2011). Complimentary & Alternative Biomedical
Treatments for ADHD. Psychiatric Annals, 41, 32-38.
202. Arnold, L. E., DiSilvestro, R. A., Boz zolo, D., Bozzolo, H., Crowl, L., Fernandez, S.,
Ramadan,Y., Thompson, S., Mo, X., Abdel-Rasoul, M., & Joseph, E. (2011). Zinc for
attention-deficit/ hyperactivity disorder: Placebo-controlled double-blind pilot trial alone
and combined with amphetamine. Journal of Child and Adolescent Psychopharmacology
21(1):1-20. doi: 10.1089/cap.2010.0073
203. Frazier T, Youngstrom E, Horwitz S, Demeter C, Fristad M, Arnold L, Birmaher B,
Kowatch R, Axelson D, Ryan N, Gill M, Findling R. The Relationship of Persistent Manic
Symptoms to the Diagnosis of Pediatric Bipolar Disorder. Journal of Clinical Psychiatry.
June 2011;72(6):846-853.
Page 28
5/16/2012
204. Findling RL, Horwitz SM, Birmaher B, Kowatch RA, Fristad MA, Youngstrom EA,
Frazier TW, Axelson D, Ryan N, Demeter CA, Depew J, Fields B, Gill MK, Deyling EA,
Rowles BM, Arnold LE. Clinical characteristics of children receiving antipsychotic
medication. J Child Adolesc Psychopharmacol 2011; 21(4):311-319.
205. Vitiello B, Elliott GR, Swanson JM, Arnold LE, Hechtman L, Abikoff H, Molina BSG,
Wells K, Wigal T, Jensen PS, Greenhill LL, Kaltman JR, Severe JB, Odbert C, Hur K,
Gibbons R: Blood pressure and heart rate in the Multimodal Treatment of Attention
Deficit/Hyperactivity Disorder Study over 10 years. Am J Psychiatry September 2, 2011
(doi: 10.1176/appi.ajp.2011.10111705).
206. Vaughn, A., Epstein, J., Rausch, J., Altaye, M., Langberg, J., Newcorn, J.,
Hinshaw, S., Hechtman, L., Arnold, L.E., Swanson, J., & Wigal, T. (in press). Relations
between neuropsychological functioning and ADHD symptomatology over time. J
Abnorm Child Psychol. 2011 August ; 39(6): 853–864. doi:10.1007/s10802-011-9501-y. 207. Tobiasova Z, Lingen KH, Scahill L, Leckman JF, Zhang Y, Chae W, McCracken JT,
McDougle CJ, Vitiello B, Tierney E, Aman MG, Arnold LE, Katsovich L, Hoekstra PJ,
Volkmar F, Bothwell AL, Kawikova I. Risperidone-Related Improvement of Irritability
in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth
Factor and Interleukin-13. J Child Adolesc Psychopharmacol. 2011 Nov 9. [Epub ahead
of print] PMID:22070180
208. Lofthouse N, Arnold LE, Hersch SB, Hurt E, DeBeus R (2011 Nov 16). A Review of
Neurofeedback Treatment for Pediatric ADHD. J. of Attention Disorders DOI:
10.1177/1087054711427530
209. Farmer, C., Arnold, L., Bukstein, O., Findling, R., Gadow, K., Li, X., Butter, E., &
Aman, M. (2011). The Treatment of Severe Child Aggression (TOSCA) Study: Trial
Design Challenges. Child and Adolescent Psychiatry and Mental Health, 5(36).
doi:10.1186/1753-2000-5-36
210. Langberg, J.M., Molina, B.S.G., Arnold, L.E., Epstein, J.N., Altaye, M., Hinshaw, S.P., Swanson, J.M., Wigal, T., & Hechtman, L. (2011). Patterns and predictors of adolescent academic achievement and performance in a sample of children with Attention-Deficit/Hyperactivity Disorder (ADHD). Journal of Clinical Child and Adolescent Psychology, 40(4), 519-531. DOI: 10.1080/15374416.2011.581620.
211. Stevens LJ, Kuczek T, Burgess JR, Hurt E, Arnold LE. Dietary sensitivities and ADHD
symptoms: 35 Years of research. Clinical Pediatrics, 50(4): 279–293, 2011.
212. Lofthouse N, Arnold LE, Hurt E. Review. Current status of neurofeedback for
attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2012 Oct;14(5):536-42. doi:
10.1007/s11920-012-0301-z.
213. Scahill, L., McDougle, C. J., Aman, M. G., Johnson, C., Handen,B., Bearss, K., Dziura,
J., Butter, E., Swiezy, N. B., Arnold, L. E., Stigler, K. A., Sukhodolsky, D. G.,
Lecavalier, L., Pozdol, S. L., Nikolov, R., Hollway, J. A., Korzekwa, P., Gavaletz, A.,
Kohn, A. E., Koenig, K., Grinnon, S., Mulick, J. A., Yu, S., & Vitiello, B., for the
Research Units on Pediatric Psychopharmacology Autism Network (2012). Effects of
risperidone and parent training on adaptive functioning in children with a pervasive
developmental disorders and serious behavioral problems. Journal of the American
Academy of Child and Adolescent Psychiatry, 51(2), 136-146.
214. Arnold LE, Demeter C, Mount K, Frazier TW, Youngstrom EA, Fristad M, Birmaher B,
Page 29
5/16/2012
Findling RL, Horwitz SM, Kowatch R, Axelson DA. Pediatric bipolar spectrum disorder
and ADHD: comparison and comorbidity in the LAMS clinical sample. Bipolar
Disorders, 2011; 13:509-21. PMCID: PMC3201827; NIHMSID: NIHMS322856
215. Hurt EA, Arnold LE, Lofthouse N. Dietary and Nutritional Treatments for Attention-
Deficit/Hyperactivity Disorder: Current Research Support and Recommendations for
Practitioners. Curr Psychiatry Rep (2011) 13:323–332, DOI 10.1007/s11920-011-0217-z
216. Arnold, L.E., Mount, K., Frazier, T.W., Demeter, C., Youngstrom, E.A., Fristad, M.A.,
Birmaher, B., Horwitz, S., Findling, R.L., Kowatch, R., Axelson, D.A., 2012. Pediatric
bipolar disorder and ADHD: family history comparison in the LAMS clinical sample.
Journal of Affective Disorders (online March 2012), 10.1016/j.jad.2012.03.015.
217. Arnold, L. E., Aman, M. G., Hollway, J., Hurt, E., Bates, B., Li, X., Farmer, C., Anand,
R., Thompson, S., Ramadan, Y., Williams, C. (2012). Placebo-controlled pilot trial of
mecamylamine for treatment of autism spectrum disorders. Journal of Child and
Adolescent Psychopharmacology, 22(3):1-8, DOI: 10.1089/cap.2011.0056.
218. Arnold LE, Lofthouse N, Hersch S, Pan X, Hurt E, Bates B, Kassouf K, Moone S,
Grantier C (2013). EEG Neurofeedback for ADHD: Double-Blind Sham-Controlled
Randomized Pilot Feasibility Trial Journal of Attention Disorders 17(5):410-419, 2013. first
published May 22, 2012 as DOI:10.1177/1087054712446173
219. Pearson, D.A., Aman, M.G., Arnold, L.E., Lane, D.M., Loveland, K.A., Santos, C.W.,
Casat, C.D., Mansour, R., Jerger, S.W., Ezzell, S., Factor, P., Vanwoerden, S., Ye, E.,
Narain, P., & Cleveland, L.A. (2012). High concordance of parent and teacher attention-
deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism
spectrum disorders. Journal of Child and Adolescent Psychopharmacology. Vol. 4, Aug.
2012.
220. Mrug, S., Molina, B.S.G., Hoza, B., Gerdes, A.C., Hinshaw, S.P., Hechtman, L., & Arnold, L.E. (2012). Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: Contributions to long-term outcomes. Journal of Abnormal Child Psychology, 40(6) 1013-1026. PMCID: PMC3384771
221. Farmer, C. A., Lecavalier, L., Yu, S., Arnold, L., McDougle, C., Scahill, L., Handen, B.,
Johnson, C., Stigler, K., Bearss, K., Swiezy, N., & Aman, M. G. (2012). Predictors and
moderators of response to behavioral treatment in children with autism spectrum disorders
and serious behavioral problems. Journal of Autism and Developmental Disorders, 42,
1037-1044.
222. Fristad, M.A., Frazier, T.W., Youngstrom, E.A., Mount, K., Fields, B.W., Demeter, C.,
Birmaher, B., Kowatch, R.A., Arnold, L.E., Axelson, D., Gill, M.K., Horwitz, S.M. &
Findling, R.L. (in press). Familial risk factors for onset of bipolar spectrum disorder in
high-risk youth. Bipolar Disorders. PubMed # 22788253NIHMSID #382512.
223. Arnold LE, Lofhouse NL, Hurt EA (2012). Artificial Food Colors and Attention-
Deficit/Hyperactivity Symptoms: Conclusions to Dye for. Neurotherapeutics 9:599-609,
2012. DOI: 10.1007/s13311-012-0133-x
224. Arnold LE, Aman MG, Li X, Butter E, Humphries K, Scahill L, Lecavalier L, McDougle
CJ, Swiezy NB, Handen B, Wilson K, Stigler KA. RUPP Autism Network randomized
Page 30
5/16/2012
clinical trial of parent training and medication: One-year follow-up. J. Amer. Acad. Child &
Adolesc. Psychiatry 51(11):1173-1184, 2012.
225. Fristad, M.A., Frazier, T.W., Youngstrom, E.A., Mount, K., Fields, B.W., Demeter, C.,
Birmaher, B., Kowatch, R.A., Arnold, L.E., Axelson, D., Gill, M.K., Horwitz, S.M. &
Findling, R.L. (2012). What differentiates children visiting outpatient mental health
services with bipolar spectrum disorder from children with other psychiatric diagnoses?
Bipolar Disorders, 14: 497-506. PubMed # 22788253 NIHMSID #382512.
226. Lofthouse N, Hendren R, Arnold LE, Hurt E, Butter E. A Review of Complementary
and Alternative Treatments for Autism Spectrum Disorders. Autism Research and
Treatment Volume 2012, Article ID 870391, 21 pages doi:10.1155/2012/870391.
227. Scahill, L., Hallett, V., Aman, M., McDougle, C. J., Arnold, L. E., McCracken, J. T.,
Tierney, E., Dziura, J., Deng, Y., & Vitiello, B. (2012). Brief report: Social disability in
Autism Spectrum Disorder: Results from Research Units on Pediatric
Psychopharmacology (RUPP) Autism Network Trials. Journal of Autism and
Developmental Disorders, 43(3), 739-746. doi: 10.1007/s10803-012-1689-3
228. Frazier, E.A., Fristad, M.A. & Arnold, L.E. Feasibility of a nutritional supplement as
treatment for pediatric bipolar spectrum disorders. J Altern Complement Med. 2012
Jul;18(7):678-85. doi: 10.1089/acm.2011.0270. Epub 2012 Jul 2.
229. Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE: A Systematic
Review and Analysis of Long-term Outcomes in Attention Deficit Hyperactivity Disorder:
Effects of Treatment and Non-treatment. BMC Medicine 2012, Vol 10: p.99; 10:99 doi:10.1186/1741-7015-10-99
230. Lofthouse, N., Arnold, L.E., & Hurt, E. Current Status of Neurofeedback for Attention-
Deficit Hyperactivity Disorder. Current Psychiatry Reports 2012 Oct;14(5):536-42.
231. Molina, B.S.G, Hinshaw, S.P., Arnold, L.E., Swanson, J.M., Pelham, W.E., Hechtman,
L., Hoza, B., Epstein, J.N., Wigal, T., Abikoff, H.B., Greenhill, L.L., Jensen, P.S., Wells,
K.C., Vitiello, B., Gibbons, R.D., Howard, A., Houck, P.R., Hur, K., Lu, B., Marcus. S &
MTA Cooperative Group. (2013). Adolescent substance use in the MTA as a function of
childhood ADHD, random assignment to childhood treatments, and subsequent
medication. Journal of the American Academy of Child & Adolescent Psychiatry, 52(3),
250-263. NIHMSID: NIHMS431581
232. Pearson, D.A., Santos, C.W., Aman, M.G., Arnold, L.E., Casat, C.D., Mansour, R.,
Lane, D.M., Loveland, K.A., Bukstein, O.G., Jerger, S.W., Factor, P., Vanwoerden, S.,
Perez, E., & Cleveland, L.A. (2013). Effects of extended release methylphenidate
treatment on ratings of ADHD and associated behavior in children with autism spectrum
disorders and ADHD symptoms. Journal of Child and Adolescent Psychopharmacology.
23: 337-351.
Page 31
5/16/2012
233. Arnold LE, Aman MG, Anand R (2012). Varenicline in Autistic Disorder: Hypothesis
and Case Report of Single-Patient Crossover. J. Child & Adolescent
Psychopharmacology, in press, 2013, DOI: 10.1089/cap.2012.0025.
234. Arns M, van der Heijden KB, Arnold LE, Kenemans L. Geographic Variation in the
Prevalence of Attention-Deficit/Hyperactivity Disorder: The Sunny Perspective.
Biological Psychiatry 2013 online. doi.org/10.1016/j.biopsych.2013.02.010
235. Stevens LJ, Kuczek T, Burgess JR, Stochelski MA, Arnold LE, Galland L Mechanisms
of behavioral, atopic, and other reactions to artificial food colors in children. Nutrition
Reviews Vol. 2013, 71(5):268–281. doi:10.1111/nure.12023.
236. The Collaborative Neurofeedback Group (incl. L.E. Arnold). A Proposed Multisite
Double-Blind Randomized Clinical Trial of Neurofeedback for ADHD: Need, Rationale,
and Strategy. J. of Att. Dis. 2013 on line; DOI: 10.1177/1087054713482580
237. Handen, B.L., Johnson, C.R., Butter, E.M., Lecavalier, L., Scahill , L.. Aman, M.G.,
McDougle, C.J., Arnold, L.E., Swiezy, N.B., Sukhodolsky, D.G., Mulick, J.A., White
S.W., Bearss, K., Hollway, J.A., Stigler, K.A., Dziura, J., Yu, S., Sacco, K., & Vitiello,
B. (2013). Use of a Direct Observational Measure in a trial of risperidone and parent
training in children with pervasive developmental disorders. Journal of Developmental
and Physical Disabilities, 25,:355–371. DOI 10.1007/s10882-012-9316-y.
238. Hafeman D, Axelson D, Demeter C, Findling RL, Fristad MA, Kowatch RA,
Youngstrom EA, Horwitz SM, Arnold LE, Frazier TW, Ryan N, Gill MK, Hauser-
Harrington JC, Depew J, Rowles BM, Birmaher B (2013). Phenomenology of Bipolar
Disorder, Not Otherwise Specified in Youth: A Comparison of Clinical Characteristics
with Bipolar I Disorder. Bipolar Disorders. 15(3): 240-252.
239. Hoza, B., McQuade, J., Murray-Close, D., Shoulberg, E., Molina, B.S.G., Arnold, L.E., Swanson, J. & Hechtman, L. (2013). Does childhood positive self-perceptual bias mediate adolescent risky behavior in youth from the MTA study? Journal of Consulting and Clinical Psychology, 81(5). 846-858. doi: 10.1037/a0033536. PMCID: PMC3961063
240. Findling RL, Jo B, Frazier TW, Youngstrom EA, Demeter CA, Fristad MA, Birmaher
B, Kowatch RA, Arnold LE, Axelson DA, et al. The 24-month course of manic symptoms
in children. Bipolar Disorders, 2013. doi: 10.1111/bdi.12100
241. Arnold LE, Hurt EA, Lofthouse N. Attention-Deficit/Hyperactivity Disorder: Dietary
and Nutritional Treatments. Child Adolesc Psychiatric Clin N Am 22 (2013) 381–402
http://dx.doi.org/10.1016/j.chc.2013.03.001
242. Borsting E, Mitchell GL, Arnold LE, Sheiman, M., Chase, C., Kulp, M., et al.
Behavioral and Emotional Problems Associated With Convergence Insufficiency in
Children: An Open Trial. Journal of attention disorders, 2013. DOI
Page 32
5/16/2012
10.1177/1087054713511528
243. Kowatch, R.A., Youngstrom, E.A., Horwitz, S.M., Demeter, C., Fristad, M., Birmaher,
B., Axelson, D., Ryan, N., Frazier, T.W., Arnold, L.E., Young, A.S., Gill, M.K., &
Findling, R.L. (2013). Prescription of psychiatric medications and polypharmacy in the
LAMS cohort. Psychiatric Services. 64(10): 1026-34. doi: 10.1176/appi.ps.201200507
244. Frazier TW, Youngstrom EA, Fristad M, Demeter C, Birmaher B, Kowatch RA, Arnold
LE, Axelson D, Gill MK, Horwitz SM, Findling RL. Improving Clinical Prediction of
Bipolar Spectrum Disorders in Youth. Journal of Clinical Medicine. J. Clin. Med. 2014,
3(1), 218-232; doi:10.3390/jcm3010218
245. Aman MG, Bukstein OG, Gadow KD, Arnold LE, Molina SG, McNamara NK,
Rundberg-Rivera EV, Li X, Kipp H, Schneider J, Buter EM, Baker J, Sprafkin J, Rice
RR, Bangalore SS, Farmer CA, Austin AB, Buchan-Page KA, Brown NV, Hurt EA,
Grondhuis SN, Findling RL. What Does Risperidone Add to Parent Training and
Stimulant for Severe Aggression in Child Attention-Deficit/Hyperactivity Disorder? J.
Amer. Acad Child Adolesc. Psychiatry, 2014;53(1):47–60.
246. Aman, M.G., Smith, T., Arnold, L.E., Corbett-Dick, P., Tumuluru, R.V., Hollway, J.A.,
Hyman, S.L., Mendoza-Burcham, M.I., Pan, X., Mruzek, D., Lecavalier, L., Levato, L.,
Silverman, L.B., Handen, B. (2014). A review of atomoxetine in young people with
developmental disabilities. Research in Developmental Disabilities, 35, 1412-1424.
http://dx.doi.org/10.1016/j.ridd.2014.03.006
247. Arnold, L.E., Ganocy, S.J., Mount, K., Youngstrom, E.A., Frazier, T., Fristad, M.,
Horwitz, S.M., Birmaher, B., Findling, R., Kowatch, R.A., Demeter, C., Axelson, D., Gill,
M.K., Marsh, L. (2014). Three-year latent class trajectories of ADHD symptoms in a
clinical sample not selected for ADHD. Journal of the American Academy of Child &
Adolescent Psychiatry. 2014, 53(7):745-760. DOI: 10.1016/j.jaac.2014.03.007
248. Carroll, D., Hallett, V., McDougle, C.J., Aman, M.G., McCracken, J.T., Tierney, E.,
Arnold, L.E., Sukhodolsky, D.G., Lecavalier, L., Handen, B., Swiezy, N., Johnson, C.,
Bearss, K., Vitiello, B., & Scahill, L. (2014). Examination of aggression and self injury in
children with autism spectrum disorders and serious behavioral problems. Child and
Adolescent Psychiatric Clinics of North America, 23 (1): 57–72.
249. Hurt EA, Arnold LE, Lofthouse N. Quantitative EEG Neurofeedback for the Treatment
of Pediatric Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorders,
Learning Disorders, and Epilepsy. Child Adolesc Psychiatric Clin N Am 23 (2014):465–
486. http://dx.doi.org/10.1016/j.chc.2014.02.001
250. McCracken, J.T., Badashova, K.K., Posey, D.J., Aman, M.G., Scahill, L., Tierney, E.,
Arnold, L.E., B Vitiello, B., Whelan, F., Chuang, S.Z., Davies, M., Shah, B., McDougle,
C.J., & Nurmi, E.L. (2014). Positive effects of methylphenidate on hyperactivity are
moderated by monoaminergic gene variants in children with autism spectrum disorders.
Pharmacogenomics Journal 14, 295–302
251. Greenfield, B., Henry, M., Lis, E., Slatkoff, J., Guile, JM., Dougherty, G., Zhang, X.,
Page 33
5/16/2012
Arnold, L. E., Daniel, L., Raz, A., Mishara, B. L., Koenekoop, R. K., & de Castro, F.
Correlates, Stability and Predictors of Borderline Personality Disorder among Previously
Suicidal Youth, European Child & Adolescent Psychiatry, 2014.
252. Silverman, L., Hollway, J.A., Smith, T., Aman, M.G., Arnold, L.E., Pan, X., Li, X., &
Handen, B. (2014). A multisite trial of atomoxetine and parent training in children with
autism spectrum disorders: Rationale and design challenges. Research in Autism Spectrum
Disorders, 8, 899-907. doi.org/10.1016/j.rasd.2014.03.013
253. Rosen, P. J., Vaughn, A. J., Epstein, J. N, Hoza, B., Arnold, L. A., Hechtman, L.,
Molina, B. S. G., & Swanson, J. M. (2014). Social self-control, externalizing behavior,
and sociometric peer liking in children with ADHD: A mediation model. Social
Development, 23, 288-305.
254. Murray, D.W., Molina, B.S., Glew, K., Houck, P. Greiner, A., Fong, D., Arnold, L.E.,
Swanson, J., Lerner, M., Hechtman, L., Abikoff, H., Jensen, P. (2014). Prevalence and
characteristics of school services for high school students with ADHD. School Mental
Health. Advance online publication. doi: 10.1007/s12310-014-9128-6.
255. Genna Bebko┼, Michele Bertocci
┼, Henry Chase, Amanda Dwojak, Lisa Bonar, Jorge
Almeida, Susan Beth Perlman, Amelia Versace, Claudiu Schirda, Michael Travis, Mary
Kay Gill, Christine Demeter, Vaibhav Diwadkar, Jeffrey Sunshine, Scott Holland, Robert
Kowatch, Boris Birmaher, David Axelson, Sarah Horwitz, Thomas Frazier, Lawrence
Eugene Arnold, Mary Fristad, Eric Youngstrom , Robert Findling, and Mary Louise
Phillips. (In press). Decreased amygdala-insula resting state connectivity in behaviorally
and emotionally dysregulated youth. Psychiatry Research Neuroimaging.
256. Fernández de la Cruz, L., Simonoff, E., McGough, J.J., Halperin, J.M., Arnold, L.E., &
Stringaris, A. (2014). Treatment of children with Attention Deficit Hyperactivity Disorder
(ADHD) and irritability: Results from the Multimodal Treatment Study of Children with
ADHD (MTA). Journal of the American Academy of Child and Adolescent Psychiatry
2015;54(1):62–70. DOI: 10.1016/j.jaac.2014.10.006
257. McQuade, J.D., Vaughn, A. J., Hoza, B., Murray-Close, D., Molina, B.S.G., Arnold,
L.E., & Hechtman, L. (2014). Perceived social acceptance and peer status differentially
predict adjustment in youth with and without ADHD. Journal of Attention Disorders, 18,
31-43. doi: 10.1177/1087054712437582
258. Algorta, G.P., Kragh, C.A., Arnold, L.E., Molina, B.S., Hinshaw, S.P., Swanson, J.M.,
Hechtman, L., Copley, L.M., Lowe, M., Jensen, P.S. (in press). Maternal ADHD
symptoms, personality, and parenting stress: Differences between mothers of children
with ADHD and mothers of comparison children. Journal of Attention Disorders.
259. Kaat, A., Farmer, C., Gadow, K., Findling, R., Bukstein, O., Arnold, L.E., Bangalore,
S.S., McNamara, N., & Aman, M.G. (2014). Factor Validity of a Proactive and Reactive
Aggression Rating Scale. Journal of Child and Family Studies. DOI 10.1007/s10826-014-
0075-5
260. Arnold LE, Hodgkins P, Kahle J, Madhoo M, Kewley G (2015). Long-Term Outcomes
of ADHD: Academic Achievement and Performance. J. Attention Disorders DOI:
10.1177/1087054714566076
Page 34
5/16/2012
261. Arnold LE, Hodgkins P,Caci H, Kahle J,Young S. (2015) Effect of treatment modality on
long-term outcomes in attention-deficit/hyperactivity disorder: a systematic review. PLoS
ONE 10(2): e0116407. doi:10.1371/journal.pone.0116407.
262. Hinshaw, S. P., & Arnold, L. E. (2015). Attention deficit hyperactivity disorder, multimodal treatment, and longitudinal outcome: Evidence, paradox, and challenge. WIRES Cognitive Science, 6, 39-52.
